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ABSTRACT
The bioinformatics applications often involve many computational components
and massive data sets, which are very difficult to be deployed on a single computing
machine. In this thesis, we designed a data-intensive computing platform for
bioinformatics applications using virtualization technologies and high performance
computing (HPC) infrastructures with the concept of multi-tier architecture, which can
seamlessly integrate the web user interface (presentation tier), scientific workflow (logic
tier) and computing infrastructure (data/computing tier). We demonstrated our platform
on two bioinformatics projects. First, we redesigned and deployed the cotton marker
database (CMD) (http://www.cottonmarker.org), a centralized web portal in the cotton
research community, using the Xen-based virtualization solution. To achieve highperformance and scalability for CMD web tools, we hosted the large amounts of protein
databases and computational intensive applications of CMD on the Palmetto HPC of
Clemson University. Biologists can easily utilize both bioinformatics applications and
HPC resources through the CMD website without a background in computer science.
Second,

we

developed

a

web

tools

―

Glycan

Array

QSAR

Tool

(http://bci.clemson.edu/tools/glycan_array), to analyze glycan array data. The user
interface of this tool was developed at the top of Drupal Content Management Systems
(CMS) and the computational part was implemented using MATLAB Compiler Runtime
(MCR) module. Our new bioinformatics computing platform enables the rapid
deployment of data-intensive bioinformatics applications on HPC and virtualization
environment with a user-friendly web interface and bridges the gap between biological
scientists and cyberinfrastructure.
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Chapter 1
Introduction
The bioinformatics application often involves many computational components
and a large number of runs with different parameters and configurations [1-4]. Recently,
the genomic research based on Next Generation Sequencing (NGS) technology makes it
possible to study biological phenomena on a large scale: all metabolic processes in a
tissue, all transcripts in a cell, and all genes in a genome. However, sequencing-based
genome-wide analysis also products massive quantities of data, which brings a new
challenge facing the current bioinformatics research [5] and finally leads to the
insufficiency of performance or capability on a local workstation or server. For example,
the amount of data from the 1000 Genomes Project [6] will reach the petabyte scale for
the raw sequence information. In the near future, the situation will be dramatically
changed by third-generation sequencing technologies [7]. It will allow us to scan entire
transcriptomes, microbiomes and genomes, and make it possible to assess epigenetic
changes directly [8] in a few minutes with the cost less than US$100. Today’s dataintensive biology drives a new emerging computational model to integrate massive data
with computing resources derived from molecular biology.
Biological research is becoming more and more dependent on big data analysis.
Biologists will soon encounter difficulties in handling missive data sets using traditional
applications or tools that were initially designed for the single machine or non-dataintensive task in such areas as protein or nucleic acid sequence assembly, sequence
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alignment for similarity comparisons, motif recognition in linear sequences or higherorder structure, and common patterns of gene expression; Further, while current
technologies can provide large-scale computing solutions to analyze, integrate and
manipulate big data sets, there still exists a huge knowledge gap for biologists with
sufficient computer science background to utilize high-end platform resources. This
shortage means biologists have to either avoid research areas relevant to big data sets or
collaborate with data scientists. Due to lack of the ability to analyze the massive data,
many promising biological projects have to be given up or cannot keep growing in longterm investments, and the ecosystem of bioinformatics research would also be limited to
a very small scope.
High-performance Computing (HPC) is a typical computing infrastructure that
provides high-performance parallel file systems with both high bandwidth and large
capacity. Parallel file systems like PVFS [9], HDFS [10], GPFS [11] and Lustre [12] are
usually employed to meet these needs and are often layered on top of clustered storage
systems or use special high-end customized hardware. These systems are geared towards
storing petabyte-scale data in a reliable fashion with high throughput for massive
computing jobs. To make the bioinformatics resource and software more accessible, and
allow for a faster overall time-to-solution, a user-friendly computing platform based on
cyberinfrastructure could be a promising way to lead biologists to a new scientific
paradigm: data-driven science.
In this thesis, we propose a platform solution for data-intensive bioinformatics
applications using virtualization technologies and HPC infrastructures. A multi-tier
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architecture is used to integrate the web user interface (presentation tier), scientific
workflow (logic tier) and computing infrastructure (data/computing tier). The platform
has been demonstrated through two bioinformatics projects: One is Cotton Marker
Database (CMD) (http://www.cottonmarker.org) which is a centralized web portal in the
cotton research community. The other project is a quantitative structure-activity
relationship (QSAR) Tool (http://bci.clemson.edu/tools/glycan_array) used to analyze
glycan array data.
The remainder of this thesis is organized as follows. Chapter 2 provides
background and terminology information, including concepts to construct our new
bioinformatics computing platform. Chapter 3 gives a detailed solution to design and
deploy data-intensive computing platform for bioinformatics applications. Chapter 4
demonstrates the CMD project on HPC and virtualization environment. Chapter 5 shows
a glycan array QSAR on our new bioinformatics platform. And finally Chapter 6 offers
conclusions and future works.
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Chapter 2
Background
Bioinformatics is an interdisciplinary field that combines aspects of Biology,
Mathematics, and Computer Science [13], which are also theoretical foundations of our
bioinformatics platform and related projects. In following sections, we introduce several
terminologies and concepts in these areas to give a basic background for the further
discussions in the remainder chapters.

2.1 Virtualization
Virtualization is a computing construct for running software (usually operating
systems) concurrently and isolated from other programs on a single computer system
[14]. Figure 2.1 shows the architecture of a virtualization platform. Typically, the
architecture of OS virtualization includes a hypervisor, a software layer or subsystem that
controls hardware and provides guest OSs with access to underlying hardware. The
hypervisor allows multiple individual guest OSs to share the same physical system by
offering virtualized hardware using various approaches (such as, full virtualization, paravirtualization and software virtualization) to mapping [15]. Guest OSs could be 32-bit or
64-bit Windows, Linux or Unix systems, which provides wide support for various
applications and services. There are many different types of virtualization platforms,
including Xen, KVM, VMware, VirtualBox, OpenVZ and Solaris containers.
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Figure 2.1 The architecture of virtualization platform
In our project, a Xen-based virtualization solution is used to support two product
websites. The Xen framework is a very popular and common solution for the Linux
platform. The Xen hypervisor contains three components, Domain 0, the Xen Hypervisor
and Multiple Domain U [14]. These run directly on top of the physical machine, and act
as the middle layer for the guest operating systems to access all hardware such as CPU,
I/O, and disk. Domain 0 is the only domain that has privileges to access the Xen
hypervisor. These privileges allow Domain 0 to manage and control all Domain Guests
(DomUs), including starting, stopping, network requests, and so on.

2.2 Machine Learning
2.2.1 Classification and Prediction
Classification, also called supervised learning, is the computational approach of
finding a model from training data and predicting the class of testing data. The model
built from training data set has the ability to characterize and distinguish prediction data
sets with a form of rules, decision tree or mathematical functions. Sample sets are usually
observations or measurements labeled with features and class. Features selected for the
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samples should relate to the classes, and the labels predicted by the classifier are usually
categorical. For models generating continuous numerical values, the labels can be
obtained by discretization. Some typical classification algorithms are decision tree,
random forest, support vector machine and naïve Bayesian.
Various approaches can be used to validate the prediction result. The cross
validation is one of the common and effective approaches. In this method, the sample
data is randomly split into n sets. One set in the middle is used for testing and the other
𝑛 − 1 sets are used for training. Totally n iterations will be conducted, and the average of
each result will be calculated to represent the performance.

2.2.2 Support Vector Machine
Support Vector Machines (SVM) [16] are a computational method for data
classification by constructing a hyperplane (or set of hyperplanes) in a high or infinite
dimensional space, which can be used for regression, classification, or other further tasks.
The original problem is often stated in a finite dimensional space in which the sets to
discriminate are not linearly separable. The principle of SVM is to map the original
finite-dimensional space into a much higher-dimensional space to make the separation
easier. A hyperplane created by the SVM is based on the largest distance to the nearest
training data points of any class (functional margin). To avoid overfitting the problem, a
buffer (soft margin) is used to provide certain error tolerances during the training stage.
There are many implementations of SVM, such as LibSVM [17], SVMlight [18] and
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TinySVM [19]. In our project, we use LibSVM tools with different kernel functions to
improvement Simple Sequence Repeats (SSR) redundancy of the CMD website.

2.2.3 Evaluation Criteria
In order to measure the performance of classification result, multiple criteria were
employed including sensitivity, specificity, precision, accuracy and F-measure. Four
basic terminologies are used to definite these criteria which are true positive (TP), false
positive (FP), true negative (TN) and false negative (FN) respectively. True positive is
the correctly predicted positive data. True negative is the correctly predicted negative
data. False positive is the predicted positive data that actually belong to the negative class.
False negative is the predicted negative data that actually belong to the positive class. The
definition of sensitivity, specificity, precision, accuracy and F-measure are shown here,
Sensitivity is the probability of correctly predicted positive data over the total
number of positive data.
Sensitity =

TP

TP+FN

(2.1)

Specificity is the probability of correctly identified negative data over the total
number of negative data.
Speci�icity =

TN

TN+FN

(2.2)

Precision is the probability of correctly predicted positive data over the total
number of predicted positive data.
Precision =

7

TP

TP+FP

(2.3)

Accuracy is the probability of correctly predicted positive and negative data over
the sum of positive and negative data.
Accuracy =

TP+TN

TP+TN+FP+FN

(2.4)

The F-measure or F-score is a measure of the accuracy of testing data by
considering both the precision and recall of the test to compute the score. The best Fmeasure score is 1 and the worst F-measure score is 0.
F=

2×(Precision×Recall)
(Precision+Recall)

(2.5)

Additionally, ROC (Receiver Operating Characteristic) curve and AUC (Area
Under Curve) value serve to evaluate the discriminate power of models, and can be used
to select the optimal models. ROC curve is used to measure the classifier in the cross
validation study and the prediction performance. ROC curve plots the fraction of true
positives against the false positive rate as the threshold of prediction varies. ROC
evaluates the performance of classifiers based on the tradeoff between specificity and
sensitivity. While ROC curve provides a visualization method to evaluate a classifier,
AUC (area under the curve) score is widely used by providing a numeric value for the
comparison of prediction performance. While an AUC value of 1 means perfect
prediction, an area of 0.5 indicates random prediction. Most common models should have
AUC values between 0.5 and 1.0. The higher the AUC value, the better the model. High
AUC value means that lowering the threshold for the prediction only brings in limited
false positive samples.
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2.3 Partial Least Squares (PLS) Regression
The PLS regression has been widely used to model the relationship between
responses and predictor variables [20]. For example, responses are the properties of
chemical samples and predicator variables are the composition of chemicals. In our study,
the response is the binding intensity of glycan chains to glycan-binding proteins and the
predictor variables are the sub-trees extracted from glycan chains. Unlike general
multiple linear regression, the PLS regression can handle strong collinear data and the
data in which number of predictors is larger than the number of observations. The PLS
build the relationship between response and predictors through a few latent variables
constructed from predictors. The number of latent variables is much smaller than that of
the original predictors. Let vector y (n×1) denote the single response; matrix X (n×p)
denote the n observations of p predictors and matrix T (n×h) denote n values of the h
latent variables. The latent variables are linear combinations of the original predictors:

Tij = ∑ Wkj X ik

(2.6)

k

where matrix W (p×h) is the weights. Then, the response and observations of predictors
can be expressed using T as follows [20]:
X ik = ∑ Tij Pjk + Eik

(2.7)

y m = ∑ C mj Tij + f m

(2.8)

j

j

where matrix P (h×p) is the is called loadings (the regression coefficients of latent
variables T for observations) and matrix C (h×1) is the regression coefficients of T for
responses. The matrix E (n×p) and vector f (n×1) are the random errors of X and y. The
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PLS regression decomposes the X and y simultaneously to find a set of latent variables
that explain the covariance between X and y as much as possible [20].
The PLS regression was performed using the plsregress function in Matlab. The
plsregress function takes three parameters: X, y and the number of components. It is
important to determine the number of components in PLS regression. We employed the
following procedure to select the number of components. We first ran the PLS regression
using a large number of components, for example, 50. The plsregress returned the
percentage of variance explained in response for each PLS component. Then, we counted
the number of components that contribute to variance explained beyond a threshold. This
number was our new number of components. In our study, we set the threshold to be
0.5% of variance explained. We then ran PLS regression again using the new number of
components.
The R2 of PLS regression is calculated using the formula: R 2 = SSerr SStotal . The
SSerr is the sum of squares of fit errors: SSerr = ∑ f 'i , where f’ (n×1) is the regression
i

errors. And the SStotal is the total sum of squares: SStotal = ∑ ( yi − y ) 2 , where y is the
i

mean of y.

2.4 GMOD
Generic Model Organism Database (GMOD) project, is a collection of open source
software tools to create and manage genome-scale biological databases [21]. There are
more than 37 components and 14 functionality areas in GMOD project. These
components provide the functionality that is needed by all organism databases like
Community Annotation, Comparative Genome Visualization, Database schema, Database
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tools, Gene Expression Visualization, Genome Annotation, Genome Visualization &
Editing, Ontology Visualization, Literature Tools, Workflow Management, Molecular
Pathway Visualization, Middleware, Tool Integration and Sequence Alignment.
In modern biology research area, bioinformatics applications and databases are
begin developed at a steady rate. However, many of these tools are seldom used since the
user may not have the resources or skills to install the tool and integrate them. There is
need for a standardized solution to integrate those tools and databases together. GMOD
provides such a platform for developers, scientists and laboratories to construct their own
bioinformatics software.

2.5 BLAST and FASTA
BLAST (Basic Local Alignment Search Tool) program [22] and FASTA program
[23] are both tools for sequence similarity search which can be used to compare a query
to a DNA/protein database by a stand-alone tool or a web interface. The difference
between BLAST and FASTA is that they use different algorithm for comparison. FASTA
is better for less similar sequences. BLAST may be faster than FASTA without
significant loss of ability to find the similar sequences in the DNA/protein database.
BLAST is one of the most widely used bioinformatics tools. There are several variants of
BLAST programs that can compare between protein or nucleotide queries with protein or
nucleotide databases.
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2.6 BioPerl
BioPerl is an open-source international project (since 1995) [5] to facilitate
sequence alignments, genetic sequence manipulation and genomic analysis. It allows
bioinformatieists, genetic researchers and computer scientists to collaboratively focus on
providing a set of well-documented Perl modules [24]. It provides a set of foundational
libraries that allow the building of complex bioinformatics tools for use in production
quality software [4] and the construction of complex solutions to bioinformatics
problems. BioPerl (version 1.6.9) gives support to read/write of multiple sequence file
formats, sequence retrieval from web databases, sequence manipulation and alignment
and sequence annotations.

2.7 Drupal
Drupal is one of most widely used open source web Content Management Systems
(CMS), which are used to create integrated web sites. Drupal web sites can include a
blog, a portal web site for the organization, an e-commerce site, a social networking site
and other componets [25]. The framework of the Drupal system is highly modular,
extensible, and standards-compliant. The official version of Drupal only contains the
basic core functionality, however, additional functionality can be added using built-in or
third-party modules. There are more than 9,000 modules available to extend and
customize Drupal functionality. To apply these modules does not require any
modifications to the code in the core.
CMS use in bioinformatics is growing [26]. Drupal is used for many applications,
including in on-line analysis tools, intranet tools, collaboration tools, biology databases,
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conference websites and lab websites. For example, Drupal is selected as the core
development framework in GMOD Tripal project [27]. The Tripal modules allow the
Drupal CMS to interact with Chado [28] data, as well as provide data loaders, display of
Chado data and administrative interfaces for data management. Our glycan array QSAR
tool also was developed as a module of Drupal platform by customizing Webform
module and Theme module. Detailed discussion will be given at the next chapter.
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Chapter 3
Bioinformatics Platform Design, Implementation and
Deployment
In this chapter, we will discuss the design, implementation and deployment of the
system platform regarding data-intensive bioinformatics applications. The primary design
goal is to create a flexible, configurable and high-performance framework with a userfriendly web interface. Based on the new design, biologists with minimal computer
science background can easily analyze massive data sets by using public computing
infrastructure. Figure 3.1 shows the architecture of the data-intensive computing platform
for bioinformatics applications using virtualization technologies and HPC infrastructures.
Detailed description of the multi-tier architecture for the bioinformatics platform is
presented in the following sections of the thesis.

3.1 Multi-tier Architecture
Our design applies the software engineering concept of multi-tier architecture
including presentation tier, logic tier and data/computing tier. It can seamlessly integrate
the web user interface, scientific workflow and computing infrastructure (Figure 3.1).
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Figure 3.1 The architecture of data-intensive computing platform for bioinformatics
applications.
Presentation tier
The presentation tier is the top layer of the platform. The presentation tier
provides user-friendly web interface related to various bioinformatics applications, such
as tools for sequence alignment in similarity comparisons, protein sequence or nucleic
acid assembly, genetic map views, SSR information retrieval, or glycan array data
analysis. All computational parameters and input data sets are submitted from this tier,
and then initial information is passed to the next tier. The presentation tier includes three
services: a form validation service, the CMS service and a search service. The interface
of this tier is implemented using HTML, Perl, PHP, JavaScript languages and the Drupal
CMS module.
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Logic tier
The logic tier is a middle layer between the presentation tier and the
data/computing tier. It acts as a workflow control center for the whole system. The logic
tier accepts task requests from the front web user interface and generates the Portable
Batch System (PBS) scripts for the HPC infrastructure based on the resource
requirements of the bioinformatics applications. In necessary, the logic tier transfers input
data sets and PBS scripts to the HPC infrastructure. It submits tasks to the task scheduler
of the HPC infrastructure, monitors status of the tasks, collects and stores task results on
the web server, parses and generates user-friendly results (e.g. Microsoft Excel format),
and sends an email to users with a summary page linked to the task directory on the web
server.
The logic tier is composed of four services: the controller, the repository, the
result server and the log server. The controller manages the life cycle of each task,
transfers, and submits all tasks to the remote HPC infrastructure. The repository is a file
archive service. It maintains a unique working directory for each task. All files including
input data sets, parameter files, PBS scripts, output result files, parsed results and log files,
are hosted in their corresponding directories. The result server receives the properly
processed results and sends the confirmation email to the users. If any unexpected
exception happens, the result server sends an error message to users and the system
administrator. Finally, the log server records the execution details for each task,
providing a real-time feedback to monitor the service quality of the current system.
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Data/Computing tier
This tier is the bottom layer of the platform. It consists of storage and computing
resources including five components: the database system, the PVFS file system, the MPI
(Message Passing Interface) library, the PBS job scheduler and bioinformatics
applications. The database system stores the relational data sets presented on the
bioinformatics website. The PVFS file system can support the management for petabytescale massive files [9], where the large amounts of protein databases and computational
intensive applications are hosted. The MPI library provides the fundamental parallel
mechanism for bioinformatics applications to achieve the high-performance and
scalability. The PBS job scheduler controls batch jobs and distributed computing
resources. Bioinformatics applications are installed on the shared storage system which
allows all computing nodes to access the same version of program.

3.2 Presentation Tier
3.2.1 CMD Web Interface
Home page
The user interface of the CMD website consists of four functional areas including
the menu area, the navigation area, the search area and the content area (Figure 3.2). The
menu area includes four main sections: General Info, View, Search and Resources. Each
has a drop down menu at the top of the home page, with further options seen along the
grey bar. The user can quickly access needed sections by moving pointer over the green
title of the link from the drop down menu, and they also can get the section name from
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navigation area. The search bar at top of the every page is a convenient way for a user to
retrieve the related information from whole website.

C

A
B

D

Figure 3.2 Home page of the CMD website. A. The menu area. B. The navigation area.
C. The search area. D. The content area.
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The primer redundancy page
The primer redundancy project page in CMD displays the results obtained from
the analysis. The summary page explains the type of analysis performed, number of
primers used, total number of redundant primers, threshold value for the analysis and the
type of redundancy. The redundant primers page provides a list of redundant primers
found in the CMD. The primer redundancy web interface can be accessed at
http://www.cottonmarker.org/primer_redundancy/. Figure 3.3 shows a query result page
of SSR ‘BNL3500’ where the user can explore all redundancy information related to the
current SSR.

Figure 3.3. The web interface for primer redundancy page. A. The number of matched
records. B. The name of the matched primer pair. C. Match type. D. Similarity of the
mached pair
Traits page
The traits page visually displays and compares linkage groups/chromosomes of
each cotton genetic cross available in CMD, including Quantitative Trait Locus (QTLs)

19

associated with the cross, as well as their exact positions on the respective chromosomes.
Overall, all CMD features are intertwined, offering simple and easy access to published
data related to cotton molecular breeding. For example, from the View Traits page
(Figure 3.4A), one can gain access to published information about the trait-associated
QTLs and nearest mapped SSR markers (Figure 3.4B), as well as detailed information
about each QTL (Figure 3.4C) and associated marker information (Figure 3.4D).
Genetic map (CMap) page
CMap is part of GMOD [29] which allows the user to browse the map of interest
and select other maps for comparisons. Users can view the number of correspondences
among all selected maps in the CMap correspondence matrix. The feature search looks
for a certain feature by name or species, accession ID and feature type. Currently, CMD
contains data for 27 genetic maps. The anchored genetic markers can be viewed in
several formats which includes an Excel spreadsheet, a database search interface, and a
graphical interface for comparative SSR maps. Figure 3.6 shows the graphical interface
of CMap in which the cotton genetic maps are displayed with anchored SSR markers, and
the SSRs location is also compared between different crosses of cotton.
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Figure 3.4 CMD Trait View Page. A. Full traits list page. B. The page for the same trait
with different properties (QTL/Gene Name, SSR Linked). C. The representative trait
information page. D. The page for associated marker.
B

A

Figure 3.5 CMD CMap Viewer. A). The index page of CMap Viewer with 27 major
genetic maps of cotton. B). An example (chromosome 24) displayed in CMap Viewer
with the associated mapped QTLs (light-green bars represent QTLs with their names on
the left).

3.2.2 BCI Glycan Array QSAR Tool Interface
To facilitate the utilization of our QSAR method by biologists to analyze their
own

glycan

array

data,

we

developed

a

web

tool

and

hosted

it

at

http://bci.clemson.edu/tools/glycan_array. The web interface as shown in Figure 3.6. The
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users first need to choose three parameters: the array version, sub-tree features and zscore for selecting significant sub-trees. They then need to paste a one-column binding
intensities of glycan array. After clicking the “Submit” button, the parameters and data
are transferred to the server. A MATLAB program on the server side will perform the
PLS regression and generate significant sub-trees. The server will then generate a results
page and send back to client. As shown in Figure 3.7, the results page contains a
summary section of input parameters and R2 value; a table of the significant sub-trees,
their regression coefficients and glycan chains containing each feature; a figure that plots
the percentage of variance explained against number of PLS components and a figure that
plots the observed intensities against fitted intensities. The user will be able to download
results and figures from the results page.

Figure 3.6 The web interface of Glycan Array QSAR Tool.
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Figure 3.7 An example result of Glycan Array QSAR Tool showed the significant monosaccharide sub-trees binding specifically to Siglec-8.
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3.3 Logic Tier
3.3.1 Data Flow on Bioinformatics Platform
The web interface is the gateway between the user and bioinformatics computing
resources. The initial information is sent from web interface and finally returned to the
front web interface again. Figure 3.8 illustrates the lifecycle of data flow on the CMD
system. The computing jobs are requested by the user from the server tools page in the
CMD website. The controller in the logical tier schedules the current computing job to
local computing server or remote HPC infrastructure based on the computing resources
which the user requests. To execute large-scale computing jobs, the user request
(including input files, parameters and an execution script) is transferred to the remote
PBS scheduler that directs the job to the HPC infrastructure. When the computing job is
finished, the controller will either send error message to the user and system
administrator or pass the original output (raw data) to the result server.
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Figure 3.8 The data flow on Cotton Marker Database. (A). Biologists retrieve the genetic
information or submit job from the thin client side. (B). CMD user-friendly web interface.
(C). Xen virtualization solution for all servers. (D). All data-intensive computing jobs are
transferred to Palmetto HPC. (E). Remote snapshot can quickly mirror all virtual
machines to another location.

3.3.2 CMD Web Tools
The tools page in the CMD website provides access to a CAP3 Assembly server,
an SSR server, and BLAST and FASTA sequence similarity search tools. These jobs are
both time- and resource-consuming, and very difficult to process on a single machine.
There are three protein databases with a total size of 16GB that need to be compared
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during each computational job. The average computational time could take more than
two weeks depending on the size of query file user submitted. In order to handle the
larger size of sequence and also reduce job running time, we redesigned the job execution
pipeline, and transfer most computational tasks to the Palmetto HPC platform. The Figure
3.9 illustrates the detailed workflow for job execution in the CMD platform.

Figure 3.9 CMD web tools execution workflow between the web server and Palmetto
HPC.
CMD web tools execution workflow including the following steps:
1. The user uploads the input file and parameters to analysis tools on CMD
website.
2. Web server generates the PBS script based on the computational job requested
by the user and then transfers all initial files (input file, PBS file, and
parameter file) to Palmetto HPC using scp.
3. All jobs are submitted to PBS scheduler of HPC.
4. Jobs are distributed to computing nodes.
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5. The job monitor keeps tracking the status of each job and sends the result back
to CMD web server after each job is done.
6. The result server parses the output file to generate the result file with Excel
format.
7. CMD web server sends an email with a link to the result page.
SSR server
SSR analysis tools are implemented using a Perl script SSRIT [30] and the FLIP [31]
program of the Organelle Genome Megasequencing Project [32]. The information of
Open Reading Frames (ORFs) is extracted by the FLIP program, and potential primers
are identified using Primer3 [33]. Users can submit a SSR job using the web-based
interface of the SSR server by uploading a batch of sequences with FASTA format and
related parameters. The result is presented by a job summary page and users also receive
an email which includes a URL link to the summary page of this job, which includes:
a) a report of the SSR analysis
b) a library file of sequences user submitted
c) a library file of the SSR containing sequences
d) an Excel file including the SSR-containing clones and its individual properties
e) detailed properties page including sequence name, repeat(s) motif and number,
length of the SSR-containing sequence, ORF start/stop position, SSR start/stop
position, SSR location relative to the ORF, primer pairs and GC content of the
sequence.
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CAP3 server
We have deployed the Contig Assembly Program called CAP3 [34] on the
bioinformatics platform to allow users to assemble ESTs. Users can submit quality files
of sequences with the percentage identity in the overlap region using the web interface.
As more ESTs are available in the public database, the unigene of cotton can be
continually refined via our CAP3 server, and more SSRs could be mined via the SSR
server.
Sequence similarity servers
CMD FASTA and BLAST servers allow users to perform homology batch
queries between their sequences and the cotton SSR sequences or protein databases by
user-friendly web interface in CMD. In the result summary page, users can retrieve an
original output file and an Excel file including any known function, the best match, match
length, alignment length, match organism, percent identity, expectation value, and start
and stop alignment positions. Our sequence similarity servers specifically designed for
processing the larger-scale jobs in cotton research areas, which can help researchers
compare new developed cotton sequences and reduce potential redundancy when
developing new markers.
Web query services
The database query service is implemented using Perl language, JavaScript
language, CPAN and BioPerl modules. Perl is a very popular and also regular
programming language in the biology area because it is so well-suited to several
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bioinformatics tasks. It is easier to use, more efficient and powerful than traditional
programming languages [35]. All query pages are dynamically generated by Apache Perl
CGI [36] module, and the result is extracted using SQL language from database. The
concept of object oriented [37] design is applied to the development of CMD website.

3.3.3 BCI Glycan Array QSAR Tool
The Glycan Array QSAR Tool provides a novel quantitative structure-activity
relationship (QSAR) method to analyze the glycan array data. It first decomposes glycan
chains into mono-, di-, tri-, or tetra-saccharide sub-trees. The bond information is also
incorporated into the sub-trees to help distinguish the glycan chains structurally. Then,
the tool performs PLS regression on glycan array data using the sub-trees as features.
Based on the regression coefficients of PLS, the tool will report the sub-trees that
determine the binding specificities of glycan-binding proteins. Figure 3.10 illustrates the
detailed job execution workflow for this tool.

Figure 3.10 The BCI Glycan QSAR tool execution workflow between web server and
Palmetto HPC.
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BCI Glycan QSAQ tool execution workflow includes the following steps:
1. The user inputs parameters and glycan array data from the web interface.
2. The form program validates the correctness of input.
3. The corresponding predictor variables are passed to the regression program.
4. Perform the MATLAB PLS regression program and generate significant sub-trees.
5. Plot figures.
6. Generate the result page.
7. Send result page to user.

3.4 Data / Computing Tier
3.4.1 Database System
There are two kinds of database management systems to serve the CMD website.
The CMD main website is a relational database implemented by MySQL open source
database version 5.0.77. Currently, the database of the CMD website contains 23 tables
that host all the data set for the SSR projects, which include information on sequences,
SSR-containing clones, primers flanking the SSRs, repeat motif, trait, project
collaborators, genetic markers and maps, open reading frame position, standardized panel
varieties, publications, data homology and primer redundancy. Figure 3.11 shows the
database schema of the CMD website.
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Figure 3.11 The database schema of CMD website
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3.4.2 Directory Structure on Palmetto HPC
Both data-intensive and computational-intensive bioinformatics jobs are
transferred to Palmetto HPC. A hierarchical directory structure (Figure 3.12) is used to
organize files (protein databases, bioinformatics applications, computing jobs, scoring
matrices and utilities) on Palmetto HPC.
/arabidopsis
/dblibs
/ExPASy
/cmd_blast
/jobs

/home

/cmd_cap3
/cmd_fasta

/CUID

/CAP3
/local

/fasta

/mat

/flip

/bin

Figure 3.12 The directory structure in Palmetto HPC
dblibs
All databases (totally 17,107,798 protein and DNA sequences) used by BLAST,
FASAT and CAP3 server are stored in this directory. When a new version of update is
released, our update script can automatically download and preprocess the new database
file.
jobs
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We deploy several popular bioinformatics applications on Clemson HPC
platform. Each computing job is assigned a unique job ID as the directory name of a
working space, where input, output and log files is archived.
local
Packages and programs of bioinformatics applications are installed in this
directory. These programs are invoked by PBS job script following with detailed
parameters and requested computing resources.
bin
This directory hosts customized utilities and scripts. For example, we develop
‘submission.sh’ utility to monitor the status of computing jobs by wrapping PBS ‘qsub’
tool. This script can hold job submit terminal and does ‘polling search’. When job finish,
the ‘submission.sh’ script can release job submit terminal. By this approach, the
workflow control module of CMD system can get a signal of job execution status
(waiting, running, success or failure) from the remote computing infrastructure.
mat
All protein similarity matrixes needed by BLAST and FASTA programs stores in
this directory.

3.5 System Services
3.5.1 Email System
The mail system is a major channel to build the communication between the user
and websites. Technically, we use Google Groups in Google Apps as the mailing list
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system, and invoke Perl CPAN module (Net::SMTP::TLS) to send the email via the
authentication SMTP protocol from the web server. Figure 3.13 shows the management
interface of mail list system. Below are two mail list groups for CMD project:
-

cmd_list@cottonmarker.org (52 users)

-

cmd_advisory@cottonmarker.org (22 users)

Figure 3.13 The management interface of CMD mail list system
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3.5.2 DNS Service
DNS service of whole system is hosted at Clemson CCIT department. The
domain name (www.cottonmarker.org) is pointed to the IP address of CMD VM web
server (130.127.48.247), and the mail exchange (MX) records is pointed to Google Apps
mail servers. Table 3.1 gives the configuration information for MX record.
Table 3.1 MX records of CMD mail servers
MX Server address
ASPMX.L.GOOGLE.COM.
ALT1.ASPMX.L.GOOGLE.COM.
ALT2.ASPMX.L.GOOGLE.COM.
ASPMX2.GOOGLEMAIL.COM.
ASPMX3.GOOGLEMAIL.COM.
ASPMX4.GOOGLEMAIL.COM.
ASPMX5.GOOGLEMAIL.COM.

Priority
10
20
20
30
30
30
30

3.5.3 Web Analytics
Web analytics is very important feature to the website, as it provides the
collection, measurement, analysis and reporting of website access data that allow us to
understand and optimize web usage [38]. In addition to measuring the website traffic, the
web analytics can also be used as a tool to track the user behavior of accessing website.
The Google Analytics [39] is a major engine used to track the access history for our
websites. Figure 3.14 shows the interface of Google Analytics, which provides
information about the number of page views and the number of visitors to a website; it
generates traffic and popularity trends which are useful for CMD user distribution
research; it also shows us how visitors found CMD website and how they interact with it.
All of this information is presented in intuitive, thorough, visual reports. Web access log
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files are archived at servers in Google instead of our server.

Figure 3.14 The interface of Google Analytics. It provides site usage, visitors, geography
location, traffics sources and records of each page

3.6 Server Virtualization
The presentation and logic tiers of bioinformatics platform are constructed using a
CentOS 5.4 Xen-based virtualization solution. We create three VMs (CMD web server,
BCI web server and database server) at the top of physical server. This design allows use
of separate different services at the OS level (Figure 3.8C). The physical server use
Logical Volume Manager (LVM) to maintain the file system. The guest VM use Logical
Volume (LV) of physical server as the local disk. LVM allows the dynamical extension
of partition space without destroying the whole file system. The guest VMs connect to
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the public network though the network bridge between domain 0 and domain U. All
packets sent or received from VMs will pass through the PREROUTING, FORWARD
and POSTROUTING iptables chains of domain 0, in which we can apply the global
security policy to monitor and filter the network traffic for all VMs.
The server virtualization provides a lot of benefits for our bioinformatics platform.
It increases the flexibility of deployment, reduces the complexity of platform design,
improves the reliability of the platform and enhances the security of the whole system.
For example, we can easily resolve the dependency conflict problem by deploying
different applications in the individual VMs. We can backup whole systems by
performing a backup of image file of VMs.
Network configuration information
There are two different types of networks, physical and virtual networks,
associated with bioinformatics platform. A physical network is a network of physical
machines that are connected each other to send and receive data. The Xen VM hosts on a
physical machine. A virtual network is a network that connects virtual machines logically
to each other on the same physical machine. The physical Ethernet adapter bridges a
virtual network and a physical network. In our bioinformatics platform, the master node
of private HPC (warriors.sc.clemson.edu) and the remote backup server use the physical
network. The CMD web server, BCI web server and database server use the virtual
network with the identifiable public IP address and host name. Table 3.2 shows the
detailed network configuration information for our bioinformatics platform.
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Table 3.2 The network configuration information
Host Name
Domain

Description

IP Address

MAC
Address

Storage

warriors.cs.clemson
.edu

The Private
HPC, hosts all
Xen VMs

130.127.48.117

00:1A:92:
69:49:9A

vmweb1.cs.clemso
n.edu

CMD web
server
www / dev
website

130.127.48.247

00:16:36:
21:f4:da

labweb1.cs.clemso
n.edu

BCI web
server
www/dev
website

130.127.48.10

00:16:36:
35:67:B6

databases

Databases
server
MySQL
PostgreSQL

130.127.49.200

00:16:3E:
7F:68:3C

roc-desktop

Remote
backup server

130.127.49.163

00:22:19:
1e:4e:ba

user.palmetto.clems
on.edu

HPC login
node

130.127.160.100

OS
/dev/md1
Data
/dev/mapper/vg0-data
OS
/dev/vg0/vm_cmdweb_os
Websites
/dev/vg0/vm_cmdweb_sites
Swap
/dev/vg0/cmdweb_swap
OS
/dev/vg0/vm_labweb_os
Websites
/dev/vg0/vm_labweb_sites
Swap
/dev/vg0/labweb_swap
OS
/dev/vg0/vm_databases_os
Database
/dev/vg0/vm_databases_data
Swap
/dev/vg0/vm_databases_swap
OS
/dev/sdb1
Backup
/dev/mapper/backuplv_backup_01
Job working directory
/home/pxuan/cmd

3.7 Backup
It is a significant challenge to automatically back up everything of our
bioinformatics platform without stopping services. An effective and reliable backup
strategy is important as well as essential since there is not a full-time system
administrator to maintain the whole system, and all system services need to stay live
without interruption.
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To meet the requirement of this situation, a robust, efficient and reliable backup
scheme is designed and implemented to support bioinformatics platform. It provides an
OS-level backup mechanism to make snapshot for each VM, and then transfers image
files of VMs to the remote storage server. In our design, we select rsnapshot [38] as the
backup tool, and use rsync [40] utility to synchronize all backups. The usage of disk
space is only the basic space of one full backup plus incrementals. Because rsnapshot
only keeps a fixed number of snapshots, the amount of disk space used will not
continuously grow. Figure 3.15 illustrates the backup schema of CMD virtualization
platform. The host domain 0 manages the physical storage as a Physical Volume (PV) by
LVM file system. Each VM has its own Logical Volume (LV) partition from the PV. For
VMs in CMD platform, this results in a single LV partition hosed on LVM. When
rsnapshot is configured to back up one of these LVs, it runs through the following steps:
a) Create temporary snapshots of VMs by their LVs
b) Mount snapshots in a temporary directory
c) Rotate the backup directory of the remote backup machine, making room for the
current backup
d) Rsync the snapshot of VMs into the remote backup location.
e) Unmount snapshots of VMs
f) Remove the temporary snapshots of VMs
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Figure 3.15 Snapshot and rsync backup solution to CMD virtualization platform
The current backup strategy is based on one week of daily backups (a rolling 7 days)
and a manually static full backup. The structure of backup directory on the remote
backup server is shown in Figure 3.16.

Figure 3.16 The structure of backup directory on the remote backup server
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Chapter 4
Cotton Marker Database
4.1 Introduction
Cotton has had a long history as an agriculturally and industrially important crop.
To improve understanding of the biological principles controlling various traits of cotton
and to enhance the economic competitiveness of cotton cultivars, large-scale genetic and
genomic studies are underway by cotton research groups worldwide [41-43]. To make
further improvement of cotton, a large amount of molecular markers have been employed
to study the tetraploid genome of cultivated cotton. In 2004, Clemson University, in
association with Cotton Incorporated, launched the Cotton Marker Database (CMD), a
public database and website that provides an easy-access to the publicly available single
nucleotide polymorphism (SNP) and SSR markers [44].
SSRs and SNPs hosed in the CMD have been developed by many research groups
all over the world within the international cotton community. In collaboration with the
principal investigators of the cotton marker development projects, we have annotated the
CMD data by arranging, analyzing, integrating and refining the data with an efficient
interface for user access. In the following sections, we describe the current CMD
database updates with the new enhancements including: new SSRs, redundancy
information of SSRs, new trait/QTL feature, extensive genetic maps, new SNP data, new
database design and structure, and enhanced web-based and community resources.
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4.2 New SSR Projects
Compared to the previously reported number of SSR markers available through
CMD [44], the current total number of cotton microsatellites has significantly increased
from 3,452 SSRs in January of 2006 to 17,448 SSRs (including 312 SSR-containing
RFLPs) by July of 2011. The 192 SSRs in the STV project were derived from multiple
tissues of Gossypium hirsutum, including 150 primer pairs screened on the CMD panel
[45]. The 2,937 SSR markers from the new MON project were provided by the Monsanto
Company [46]. Bioinformatics analysis of the MON SSR sequences and primer pairs in
comparison with the cotton SSR sequences already present in public databases revealed
that these SSR primer pairs and target genomic sequences are unique and amplify about
4,000 unique marker loci in a tetraploid cotton genome depending on the germplasm
analyzed [46]. Another new SSR project, DPL, contributed by the Delta and Pine Land
Company, includes 200 microsatellites developed from G. hirsutum small insert genomic
libraries enriched with multiple microsatellite motifs. Seven hundred SSRs from the new
Gh project were initially evaluated for internal structure and potential for homodimer and
heterodimer formation using publicly available web-based applications [47].
The HAU SSR project including 3,382 microsatellites was developed at the
Huazhong Agricultural University. HAU001-HAU119 markers were developed and
evaluated from 98 unique ESTs from the cDNA library of 2 – 25 day post anthesis (DPA)
developing fibers from G. barbadense cv. Pima 3-79. Markers HAU120-HAU205 were
developed from G. barbadense cv. Pima 3-79 using two different approaches: (i) cloning
of ISSR amplified fragments and (ii) amplification using degenerate primers. A total of
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1,831 new EST-SSRs were developed from the assembled cotton ESTs in the TIGR
database (http://www.tigr.org): 346 from G. arboretum (HAU231-HAU576), 293 from G.
raimondii (HAU577-HAU869), and 1192 from G. hirsutum (HAU870-HAU2061); 1047
unique EST-SSRs (HAU2062-HAU3108) were developed from ESTs released by Yuxian
Zhu; 299 novel EST-SSRs (HAU3109-HAU3407) were developed from ESTs from
developing fiber of G. barbadense acc. 3-79 [48, 49].
In addition, 2,233 markers from the NBRI SSR project (263 genomic SSRs and
1,970 EST-SSRs) were developed using four genomic libraries microsatellite-enriched
for CAn, GAn, AAGn and ATGn repeats, as well as the transcriptome sequencing of five
cDNA libraries of Gossypium herbaceum. Lastly, 312 SSR-containing RFLPs were
included for the PGML project [50] .
All new SSRs were incorporated into the existing CMD data display structure,
with the SSR Project pages, View and Search pages, updated Homology and Downloads
pages. On the SSR View Page, the marker name is linked to a detail page including
marker info, sequence type, location of longest ORF and repeat motifs in the sequence.
The FASTA and BLAST server databases were updated with all the new SSR sequences
from different projects as separate databases, which allow CMD users to perform a batch
query using a specific SSR project. In addition, three major protein databases used in the
BLAST and FASTA servers in the Tools section were updated with the latest versions:
UniProtKB/Swiss-Prot (release 2011.08), UniProtKB/TrEMBL (release 2011.08), and
TAIR Arabidopsis (release 2010.12). Homology searches were performed for 1712,448
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SSR sequences using all three updated protein databases. Recent homology search results
are available on the CMD Downloads page (Homology Data section).

4.3 Primer Redundancy Information of SSRs
Currently, 18,002 CMD microsatellite primer sequences have been checked using
the CMD primer redundancy analysis tool. Any of the following criteria were considered
as redundant: (i) identical primer pairs; (ii) identical forward primers; (iii) identical
reverse primers; (iv) forward primer identical to reverse and vice versa. From this
analysis, 85.7% of the microsatellite primer sequences checked were considered to be
unique and noted accordingly in the database. The Primer redundancy analysis tool is a
Perl package built around the pair wise comparison algorithm to create clusters of
identical sequences in accordance to the threshold value specified for the analysis. The
primer redundancy threshold value is the "global sequence identity" calculated as number
of identical nucleotides in alignment divided by the full length of the shorter sequence.
Based on the input threshold value, we construct clusters of sequences and search for
identity. A threshold of 0.81 (81%) was chosen for the analysis after plotting the
threshold values from 70% to 100% against the redundant primer counts. Table 4.1 gives
the summary of primer redundancy to the threshold 81%. In Figure 4.1, the redundant
primer counts are obtained for each of the individual threshold values.
In the first quarter of 2009 the new feature Primer Redundancy was added to the
View section. In the third quarter the section was updated with the new primer
redundancy results. The new results were obtained after performing further data analysis
based on the presence of the combined redundancy of the SSR primer sequences and
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repeat motifs. MON SSR project data was not included in the primer redundancy analysis
due to the lack of data on the target repeat motifs.
Table 4.1 The summary of primer redundancy processing.
Number of primer sequences analyzed (forward and reverse)
Total number of redundant primer sequences found
Total number of non-redundant primer sequences
Threshold value for the analysis
Total number of redundant primer pairs
Total number of completely matched sequence pairs (match percentage
100)
Total number of closely matched sequence pairs (match percentage 90-99)
Total number of closely matched sequence pairs (match percentage 81-89)
Type of primer sequence match (pairs)
Forward-forward match
Reverse-reverse sequence match
Forward-reverse sequence match
Reverse-forward sequence match
Both forward-forward and reverse-reverse match
Note: data presented in the table was retrieved from the CMD website.

18,002
2,570
15,432
81
1,422
940
280
202
460
414
232
316
103

Figure 4.1 The redundant primer counts obtained for each of the individual threshold
values
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4.4 SSR Redundancy Detection using SVM Machine Learning
Approach
Microsatellites or SSRs are used as molecular markers with wide-ranging
applications in the field of cotton molecular breeding. CMD provides centralized access
to publicly available cotton molecular data. In collaboration with the contributing
researchers, we have summarized and provided high quality data for 17,488 SSRs
displayed through CMD. However, SSR redundancy is common and inevitable issue for
projects coming from different research groups. The method of SSR redundancy
detection using the SSR-containing sequence alignment approach gives high number of
false-positives even when applying stringent parameters, since the similarity
identification is based only on the sequence comparison. To improve the accuracy of the
redundant SSRs detection and to reduce the cost of expert intervention, we propose the
application of machine learning based on the SVM machine learning approach.

4.4.1 Materials and Methods
We choose LIBSVM program [51] as machine learning program because it has
efficient multi-class classification, and we use cross validation method. We weight SVM
for unbalanced data. Specially, LIBSVM can automatically select the model that can
generate the contour of greatest cross valuation accuracy. This feature lets us more easily
evaluate and select parameters for our SVM program. Figure 4.2 presents the workflow
of SVM filtration with three phases: generate SVM model via the training data, verify the
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performance via the testing data, and predict/refine SSR redundancy based on the result
of sequence similarity.

Figure 4.2 The SVM machine learning workflow.
The feature selection for machine learning is a critical and also challenging task,
which usually requires an iterative approach. For our current problem we select a set of
five features related to properties of SSRs which are likely to influence a human expert
when classifying an SSR redundancy, including: percentage match for primer
redundancy, primer match type, motif similarity, percentage match for SSR sequence and
map position in the genetic map. The first four SSR features are selected for the machine
learning approach, and the last feature is used to help the expert to verify the predicted
result. The CMD SSR dataset (847 markers) is used as training, testing and prediction
sets for the SVM algorithm. Table 4.2 describes the algorithm for the training data
selection.
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Percent match of primer sequences: The SSR primer sequence is an important
referenced factor in genetic research. It is used to isolate targeted sections of DNA for
amplification in PCR. The primer sequence alignment can be calculated by CD-HIT
program [52].
Primer match type: Type 1 - forward to forward match, and reverse to reverse
match; Type 2 - forward to reverse match, or reverse to reverse match.
Motif similarity: SSR motif similarity is another important factor reflecting the
degree of SSR redundancy.
Percent match of SSR-containing sequences: BLAST search allows the
comparison for a pair of SSRs, and identify them above a certain threshold.
SSR genetic map position: Based on this feature, the training data were manually
selected and the final results were evaluated.

4.4.2 Result
The SVM approach with different kernel functions is applied to develop an
accurate model for SSR redundancy detection. In our experiment, we select four different
Kernel Functions to compare the performance of SVM based on optimal parameters C =
512 and gamma = 0.0078125. The ROC curve analysis which is generated based on the
cross validation results (Figure 4.3) indicate the remarkable performances of the SVM
approach. The high accuracy and F-score in Table 4.3 shows that the SVM-based
machine learning method can identify SSR redundancy with the high predictive
performance.
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Table 4.2 The algorithm to select the SSR redundancy training data.
No.

Action

Condition

Case 1

No mapping data for any marker.

Case 2

Two markers present once on the same chromosome of same map.

Case 3

OMIT

Two markers mapped once on the same chromosome of two
different genetic maps, two chromosome bridged by 0 or 1 marker.

PROCEED
OMIT

Either of the two markers present more than once on same
Case 3
(A)

chromosome of same map (one of the 2 or both may provide

OMIT

clue for redundancy).
Two markers mapped once on the same chromosome of two
Case 4

different genetic maps, two chromosome bridged by at least 2

PROCEED

flanking markers each mapped once.

Two markers mapped once on same chromosome of two
Case 4
(A)

different maps, but among flanking bridged markers one being

PROCEED

in paralog duplication
Note: The four cases presented above are exclusive to each other. The process may be
iterative. Once a first pair of markers has been validated (e.g. marker 1 and marker2 are
synonyms), they may become informative in terms of additional bridges for others: for
the next pair of markers formerly under case 3 this new information may result in a case
4 situation.
Table 4.3 Evaluation of results obtained for the tested data.
Kernel
Function
Linear
Polynomial
Radial
Basis
sigmoid

TP

FP

TN

FN

98
0

2
0

117
119

2
100

98%
0%

98.32%
100.00%

98.00%
--

98.17%
54.33%

Fscore
98.00
--

97

2

117

3

97%

98.32%

97.98%

97.71%

97.31

99

3

116

1

99%

97.48%

97.06%

98.17%

98.02

Sensitivity Specificity Precision Accuracy
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Figure 4.3 ROC curve analysis

4.5 QTL/Traits Feature and Cotton Genetic Maps
In breeding, cotton cultivars have been grown and cross-bred to produce desirable,
agronomically important traits, which are very often associated with combinations of
several genes, called Quantitative Trait Loci (QTLs). To better understand and determine
where particular traits of interest are located on chromosomes of a specific species of
cotton, researchers have identified a large number of DNA molecular markers linked to
certain traits and corresponding QTLs. These molecular markers include, but are not
limited to, SNPs and SSRs, or microsatellites.
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The total number of agriculturally important cotton traits displayed through CMD
is currently 44, which corresponds to 76 trait symbols and 884 mapped QTL positions on
14 cotton genetic maps. The QTL information has been uploaded into the CMD
Comparative Map Viewer (CMap) accessible from the CMD Homepage.
In the past four years, 23 new cotton genetic map sets (21 genetic maps
corresponding to individual crosses, 1 consensus map and 1 reference map), were added
to the previously available 4 genetic maps, were added to the CMap Viewer [53] on the
CMD website. In addition, we annotated the CMD cotton traits with the related
information about the trait-associated genetic markers from the cotton genetic maps and
represented their associations through the CMD-CMap connection. Specifically, the traits
are annotated and linked in CMD with the trait description, aliases, published symbol(s),
QTL/gene name(s), associated CMD marker(s), cross name(s), marker interval for QTLs,
R-square value, genetic

linkage group information, genetic map positions and

corresponding publications.
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Chapter 5
Quantitative Structure-activity Relationship (QSAR) Study on
Glycan Array Data
5.1 Introduction
Glycan-binding proteins play critical roles in many physiological and pathological
processes [54], including inflammation and cancer [55-57], growth and development [5860] and microbial pathogenesis [61-64]. In order to understand the biology of glycanbinding proteins, it is essential to identify their glycan-binding specificities. Recently,
glycan array technology [65-68] provided a high throughput method to simultaneously
measure the binding levels of a certain glycan-binding protein to a large number of
glycan molecules. The newest version (V5.0) of the glycan array from the Consortium for
Functional Glycomics (CFG) [66] contains 611 glycan chains. Currently, large amounts
of

glycan

array

data

are

freely

available

on

the

CFG

website

(www.functionalglycomics.org), and this number is still increasing. These glycan array
data have opened up opportunities to discern the binding specificities for glycan-binding
proteins.
The glycan array data usually are very complex, and simple visual inspections
may not be able to identify the binding specificities of glycan-binding proteins. This
poses a great challenge to extract binding specificities of glycan-binding proteins from
glycan array data [69]. Recently, Porter et al. (2010) proposed motif-based methods to
discern the sub-structures that contribute to the binding intensities of glycan array to a
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specific glycan-binding protein. Porter et al. manually generated a list of 63 motifs that
are sub-structures of glycan chains identified previously by biological experiments. By
comparing the enrichment of those motifs in high intensity and low intensity data
(intensity segregation) or by statistical testing between glycan data with a certain motif
and glycan data without a certain motif (motif segregation), Porter et al. (2010) were able
to find motifs that represent binding specificities. However, such predefined motifs may
not be sufficient to identify all glycan binding specificities.
We have developed a novel quantitative structure-activity relationship (QSAR)
method to analyze glycan array data. First, we automatically generated different size subtrees from glycan chains as our features. Then, we established the relationship between
sub-tree features and glycan array data using the PLS regression. We demonstrated our
QSAR method on glycan array data of different glycan-binding proteins. We were able to
identify sub-trees that represent the glycan binding specificities of glycan-binding
proteins using the regression coefficients of PLS regression. We also showed that the
sub-tree features may be better representations of the glycan binding specificity than the
motifs defined by Porter et al. (2010) are. Furthermore, we developed a user-friendly web
tool to facilitate the rapid and automatic analysis of glycan array data. A complete
description of our results and methods is given in the sections below.
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5.2 Results
5.2.1 Coding Glycans using Sub-tree Features
Glycan chains consist of different kinds of saccharides, such as glucose (Glc),
fucose (Fuc), galactose (Gal), N-acetylglucosamine (GlcNAc), mannose (Man), and Nacetylgalactosamine (GalNAc). The structure of a glycan chain can be represented as a
rooted tree. Figure 5.1 shows an example glycan chain that consists of five different
saccharides. The binding specificity of a glycan chain to glycan-binding protein usually
relies only on its substructures [64, 69]. In order to capture the structure characteristics
of glycan chain, we parsed the glycan tree into four sets of sub-trees [70, 71], each of
which has mono-, di-, tri-, or tetra-saccharide sub-tree respectively. Figure 5.2 shows that
the example glycan chain in Figure 5.1 has been decomposed into five mono-saccharide
sub-trees, five di-saccharide sub-trees, five tri-saccharide sub-trees, and four tetrasaccharide sub-trees, respectively. For each version of glycan array from the Consortium
for Functional Glycomics (CFG) [66], we generated four sets of sub-trees for the glycan
on the array, including mono-, di-, tri-, and tetra-saccharide sub-tree sets. For example,
the CFG glycan array version 2.0 contains 264 glycan chains. We obtained 112 monosaccharide sub-trees, 280 di-saccharide sub-trees, 385 tri-saccharide sub-trees and 318
tetra-saccharide sub-trees from those 264 glycan chains. The four sets of sub-trees for the
CFG glycan array version 2.0 are listed in Appendix A Table A-(I-IV).
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Figure 5.1 An example of glycan chain and its structure. The Sp denotes the spacer arm
attached to array.

Figure 5.2 An example of decomposing the glycan chain in Figure 5.1 into different subtrees. The N indicates the number of saccharide in each sub-tree.
In order to represent better the sub-structural characteristics, we included also the
bond information in the sub-trees. For each saccharide, we included the positions of its
bond connections in its representation. Different mono-saccharide sub-trees will be
generated if the same saccharide has different bond connections. For example, we had
five mono-saccharide sub-trees for galactose (Gal): (2, 3Galβ); (2, 3Galβ1); (2, 4Galβ1);
(2Galβ) and (2Galβ1) from the glycan chains of CFG version 2.0 array. Furthermore, the
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di-saccharides are also represented differently if the bonds between the same pair of
saccharides are different. For example, we had two di-saccharide sub-trees between Nacetylglucosamine

(GlcNAc)

and galactose

(Gal):

(3,4GlcNAcβ1-3Galβ1)

and

(3,4GlcNAcβ1-4Galβ1). With the bond information, the sub-trees extracted from glycan
chains can help distinguish the glycan chains structurally to a certain extent.
After obtaining the sub-trees, we used them as features to code the structures of
glycan chains on the glycan array. This new coding system has an advantage over the
motif-based approach in which the sub-tree features are more precise and more flexible.
Many sub-structures potentially cannot be represented well in motif-based features since
there have been only 63 defined motif features (Porter, A., et al. 2010). In contrast, the
number of sub-tree features in our method can be much larger (e.g. 112 mono-saccharide
sub-trees, 280 di-saccharide sub-trees, 385 tri-saccharide sub-trees and 318 tetrasaccharide sub-trees for the CFG glycan array version 2.0). Our method requires more
computation than the motif-based method, but this fact shall not be considered a
significant limitation of our method.
The structures of glycan chains were obtained from the CFG website. The CFG
glycan array version 2.0 data of plant lectins were also downloaded from the CFG
website. Table 5.2 list all 52 plant lectins that we analyzed.
For each glycan chain in a certain version of CFG glycan array, we coded one
vector based on each set of mono-, di-, tri-, or tetra-saccharide sub-trees. The elements in
each vector were 1 and 0. If a glycan chain contains a sub-tree, we coded the feature with
1; otherwise, we coded the feature with 0. Then, feature vectors were used for PLS
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regression study. A Java program was implemented to automatically parse the glycan
chains into mono-, di-, tri-, or tetra-saccharide sub-trees, and then code the glycan chains
with different sub-trees.

5.2.2 PLS Regression on Glycan Array Data using Different Features
We first applied the PLS regression to the glycan array data of three plant lectins:
Concanavalin A (ConA), Vicia Villosa Lectin (VVL) and Wheat Germ Agglutinin
(WGA), which were also studied by motif-based methods [69]. The binding specificities
of ConA and VVL are relatively simple. A visual inspection may help to identify some
common features from the data. For example, it is shown clearly from the data that ConA
binds to the glycans that contain terminal N-acetylglucosamine (GlcNAc). On the other
hand, the binding specificity of WGA is broad and cannot be determined easily by visual
examination. To understand how different sub-structures contribute to binding
specificity, we performed PLS regression studies on the glycan array data of those three
plant lectins using the mono-, di-, tri-, and tetra-saccharide sub-tree features as well as the
motif features of Porter et al. (2001). We first examined the percentage of variances of
binding intensities that can be explained using PLS regression models. The percentage of
variance explained measures the amount of variation in the given data that a regression
model accounts for and it can be used to indicate how well the regression model is. The
higher the percentage of variance explained is, the better the PLS regressions perform and
the better the sub-tree features are. Figure 5.3 plots the percentage of variance explained
in the binding intensities of three plant lectins against the number of latent variables
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(components) in PLS regression. The number of components is automatically determined
by their contributions to the variance (see Method section for more details). Thus, the
number of components varied for PLS regressions using different features. Figure
5.3Figure 5.3 shows that the PLS regression using di-saccharide sub-trees achieved the
highest percentage of variance explained for all three glycan array data. The PLS
regression using mono-saccharide sub-trees achieved high percentage of variance
explained in glycan array of ConA and the PLS regression using tri-saccharide sub-trees
achieved high percentage of variance explained in glycan array of WGA. The PLS
regression using tetra-saccharide sub-tree and motif features did not obtain high
percentage of variance explained in all three glycan array data. Thus, the tetra-saccharide
sub-tree and motif features cannot fully capture the intensity variations in those glycan
array data. These results implied that the motif-based method may not have sufficient
sensitivity to cover all binding specific sub-structures.

59

Figure 5.3 Plot of the percentage of variance explained in the binding intensities of
glycan array data of three plant lectins against the number of components in PLS. Four
sub-tree features and the motif features of Porter et al. [69] are used for PLS regression.
A) ConA, B) VVL, C) WGA.
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Then, we calculated the R2 statistics of PLS regressions. The R2 is a statistical
measurement indicating how well a regression approximates real data. The R2 analysis
(Table 5.1) is consistent with these results of variance explained above. For ConA, the
PLS regressions with all five features can obtain an R2>0.8. For VVL, only the PLS
regression using di-saccharide sub-trees as features can obtain a significant high
R2=0.9955. For WGA, the PLS regression using both di- and tri-saccharide sub-trees can
obtain high R2>0.8. Those results confirmed that di-saccharide sub-trees are good
features for characterizing the glycan array data of three plant lectins. We also tested the
PLS regression using di-saccharide sub-trees on glycan array data of more than 50 plant
lectins (Table 5.2). We obtained good results (R2>0.8) on most of the glycan array data
except two of them, which have good regression results using tri-saccharide sub-trees as
features. To further examine the results of PLS regressions, we plotted the observed
intensities against the fitted intensities calculated by PLS regression using di-saccharide
sub-trees for all three plant lectins. As shown in Figure 5.4, there are good correlations
between the observed intensities and fitted intensities for ConA, VVL and WGA. The
dots in Figure 5.4C are distributed more widely than those in Figure 5.4A and Figure
5.4B, which is consistent with relatively low R2 value obtained by the PLS regression on
glycan array data of WGA. Those plots implied that the di-saccharide sub-trees can
represent the binding specificity of ConA, VVL and WGA well.

61

Table 5.1 The R2 of PLS regressions on glycan array data of different glycan-binding
proteins using different features.
Motifs
Mono
Di
ConA
0.8052
0.9428
0.9539
VVL
0.4943
0.6893
0.9955
WGA
0.6242
0.7132
0.9002
PNA
0.7774
0.5752
0.9603
SNA
0.6760
0.7871
0.9085
DC-SIGN
0.4190
0.5490
0.9179
Siglec-8
N/A
0.9882
0.9927
Note: The highest values of R squares are highlighted in bold.

Tri
0.8276
0.7461
0.8742
0.9966
0.7431
0.9533
0.9969

Tetra
0.8021
0.3024
0.7027
0.7619
0.6509
0.8521
0.9949

Table 5.2 The highest R2 of PLS regressions on glycan array data of different glycanbinding proteins.
Glycanbinding
protein name
AAL
ABA
ACL

AMA
APA
ASA
BPL
CA
CAA
ConA
Crocus
CSA
DBA
ECA

Glycan-binding protein full
name
Aleuria Aurantia Lectin
Agaricus bisporus agglutinin
(mushroom)
Amaranthus cruentus lectin
(red amaranth, purple
amaranth)
Arum maculatum agglutinin
(lords and ladies)
Allium porrum agglutinin
Allium sativum
agglutinin/lectin
Bauhinia purpurea
agglutinin
Cymbidium agglutinin
Caragana arborescens
agglutinin (Siberian pea tree)
Concanavalin A (Canavalia
ensiformis, jack bean)
Crocus Vernus Agglutinin
Cytisus sessilifolius
agglutinin (Portugal broome)
Dolichos biflorus agglutinin
(horse gram)
Erythrina cristagalli
agglutinin (cocks comb coral
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Number of
PLS
component
9
10

R2

Features
Vector Used

0.941
0.8904

Di
Di

13

0.9939

Di

8

0.9022

Tri

8
13

0.9189
0.9018

Tri
Di

10

0.937

Di

8
11

0.9503
0.8852

Di
Di

10

0.9539

Di

12
13

0.8017
0.9926

Di
Di

14

0.9711

Di

10

0.9173

Di

EEL
GNL
GSL_I
GSL_II
HHL
Jacalin_CoreD
Jacalin_CoreH
LCA
LEL
LTL
MAA
MAL_CoreD
MAL_CoreH
MPA
MPL
NPL
PHA_L
PMA

PNA
PSA
PTL_I

PTL_II

RCA_I

tree)
Euonymus Europaeus Lectin
Peanut nodule lectin
(Arachis hypogaea)
Gerardia savaglia lectin
(false foxglove)
Gerardia savaglia lectin
(false foxglove)
Hippeastrum Hybrid Lectin
Artocarpus heterophyllus
(bread fruit tree)
Artocarpus heterophyllus
(bread fruit tree)
Lens culinaris agglutinin
(lentil)
Loranthus europaeus lectin
(loranthus, misteltoe)
Lotus tetragonolobus
agglutinin
Maackia amurensis
agglutinin/lectin
Maackia amurensis
agglutinin/lectin
Maackia amurensis
agglutinin/lectin
Maclura pomifera agglutinin
Maclura pomifera agglutinin
Narcissus pseudonarcissus
agglutinin/lectin
Leucoagglutinating isolectin
of PHA
Polygonatum multiflorum
lectin (common Solomon's
seal)
Arachis hypogaea agglutinin
(peanut)
Pisum sativum agglutinin
(garden pea, common pea)
Psophocarpus
tetragonolobus agglutinin
(goa bean, winged pea)
Psophocarpus
tetragonolobus agglutinin
(goa bean, winged pea)
Ricinus Communis
Agglutinin I
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10
17

0.8801
0.9616

Di
Di

11

0.9671

Di

9

0.9542

Di

10
13

0.9495
0.9637

Di
Di

12

0.9424

Di

12

0.9935

Di

12

0.9221

Di

14

0.9157

Di

13

0.977

Di

14

0.992

Di

15

0.9214

Di

10
12
10

0.995
0.9967
0.9436

Di
Di
Di

13

0.8511

Di

10

0.9148

Di

12

0.9122

Di

10

0.9815

Di

10

0.993

Di

9

0.9472

Di

10

0.8998

Di

Rcroc
SBA
SJA

SNA
SNA_I
SNA_II
SNA_III
SNA_IV
SNA_V
STL
UEA_I
VFA
VVL
WFA

WGA

Rhizoctonia crocorum
Soybean agglutinin (Glycine
max, soya bean)
Sophora japonica agglutinin
(Japanese/Chinese pagoda
tree)
Sambucus nigra agglutinin
(elderberry, eldertree, elder)
Sambucus nigra agglutinin
(elderberry, eldertree, elder)
Sambucus nigra agglutinin
(elderberry, eldertree, elder)
Sambucus nigra agglutinin
(elderberry, eldertree, elder)
Sambucus nigra agglutinin
(elderberry, eldertree, elder)
Sambucus nigra agglutinin
(elderberry, eldertree, elder)
Solanum tuberosum
agglutinin (potato)
Ulex europaeus agglutinin
(furze, gorse)
Vicia fava
Vicia villosa agglutinin
(hairy vetch)
Wisteria floribunda
agglutinin (Japanese
wisteria)
Wheat germ agglutinin
(Triticum vulgare)
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18
11

0.8209
0.9801

Di
Di

8

0.8408

Di

19

0.9072

Di

12

0.902

Di

12

0.8459

Di

11

0.9567

Di

10

0.9782

Di

12

0.9705

Di

10

0.9617

Di

10

0.9149

Di

11
11

0.9625
0.9954

Di
Di

10

0.9322

Di

10

0.8997

Di

Figure 5.4 Plot of observed intensities against the fitted intensities calculated by PLS
regression using di-saccharide sub-trees as features. The black lines indicate the line of
y=x. A) ConA, B) VVL, C) WGA.
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5.2.3 Identification of Significant Structural Features in Glycans
The PLS regression has established the relation between the response y and
original predictors X as a multiple regression model:

y m = ∑ Bmk X ik + f ' m

(5.1)

k

where vector f’ (n×1) denote the regression errors and matrix B (p×1) denote the PLS
regression coefficients and can be calculated by:

Bm = ∑ C miWki

(5.2)

i

Then, the significant predictors can be selected based on the values of regression
coefficients from PLS regression, which is called the PLS-Beta method [72].
To select the significant sub-trees using regression coefficients, we modeled the
distribution of regression coefficients as a Gaussian distribution. The plots of the
regression coefficient distribution obtained from PLS regression on three plant lectins
showed that approximating the coefficient distribution as Gaussian distributions is
reasonable (Figure 5.5, Figure 5.6 and Figure 5.7 ). Then, we determined the significant
regression coefficients based on z-score: z =

Bi − u

σ

, where u is the average of regression

coefficients and σ is the standard deviation of regression coefficients. We first calculated
the z-score value for each coefficient. We selected the sub-trees whose regression
coefficients with z-score larger than a threshold. The higher the z-score, the less number
of sub-trees are selected.
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Figure 5.5 The distribution of PLS regression coefficients (Beta values) obtained from
glycan array data of ConA.

Figure 5.6 The distribution of PLS regression coefficients (Beta values) obtained from
glycan array data of VVL.
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Figure 5.7 The distribution of PLS regression coefficients (Beta values) obtained from
glycan array data of WGA.
We applied the PLS-Beta method (see Methods section for more details) to
identify significant sub-trees from the PLS regressions of glycan array data. Table 5.3,
Table 5.4 and Table 5.5 list the significant di-saccharide sub-trees binding to three plant
lectins. A significant positive coefficient value indicates the corresponding sub-trees have
high binding intensities whereas a negative coefficient value suggests the existence of the
sub-tree feature will reduce the binding intensity. A negative co-efficient value can be
achieved when two glycan chains contain the same sub-tree structure, one with high
binding intensity and the other with low binding intensity. For ConA, we identified nine
di-saccharide sub-trees, which cover all 19 glycan chains (Table 5.3) with high binding
intensities. Among these nine di-saccharide sub-trees, alpha-linked mannose (Man) is
involved in seven, and four of these alpha-linked mannoses locate at terminal. Both
motif and intensity segregation methods [69] ranked the “terminal Mannoseα” as a
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significant motif. The QSAR results showed internal alpha-linked mannose may also
contribute to the binding specificity of ConA as four of our significant di-saccharides
contained internal alpha-linked mannose. The QSAR method identified that a disaccharide: 3,6Manβ1-4GlcNAcβ1, contributed to binding of 10 glycan chains in CFG
glycan array version 2.0:
•

50 (Manα1-3(Manα1-6)Manβ1-4GlcNAcβ1-4GlcNAcβ-Gly)

•

51 (GlcNAcβ1-2Manα1-3(GlcNAcβ1-2Manα1-6)Manβ1-4GlcNAcβ1-4GlcNAcβGly)

•

52 (Galβ1-4GlcNAcβ1-2Manα1-3(Galβ1-4GlcNAcβ1-2Manα1-6)Manβ14GlcNAcβ1-4GlcNAcβ-Gly)

•

53 (Neu5Acα2-6Galβ1-4GlcNAcβ1-2Manα1-3(Neu5Acα2-6Galβ1-4GlcNAcβ12Manα1-6)Manβ1-4GlcNAcβ1-4GlcNAcβ-Gly)

•

54 (Neu5Acα2-6Galβ1-4GlcNAcβ1-2Manα1-3(Neu5Acα2-6Galβ1-4GlcNAcβ12Manα1-6)Manβ1-4GlcNAcβ1-4GlcNAcβ-Sp8)

•

192 (Manα1-6(Manα1-2Manα1-3)Manα1-6(Manα1-2Manα1-3)Manβ14GlcNAcβ1-4GlcNAcβ-Asn), 193 (Manα1-2Manα1-6(Manα1-3)Manα16(Manα1-2Manα1-2Manα1-3)Manβ1-4GlcNAcβ1-4GlcNAcβ-Asn)

•

194 (Manα1-2Manα1-2Manα1-3(Manα1-2Manα1-3(Manα1-2Manα1-6)Manα16)Manβ1-4GlcNAcβ1-4GlcNAcβ-Asn)

•

197 (Manα1-6(Manα1-3)Manα1-6(Manα1-2Manα1-3)Manβ1-4GlcNAcβ14GlcNAcβ-Asn)
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•

198 (Manα1-6(Manα1-3)Manα1-6(Manα1-3)Manβ1-4GlcNAcβ1-4GlcNAcβAsn)
This di-saccharide is a subset of both “N-glycan high mannose” and “N-Glycan

complex” that are identified as significant motifs by both motif and intensity segregation
methods [69]. The “N-glycan high mannose” motif is defined by Porter et al. (2010) as “a
glycan

chain

with

a

Manα1-3(Manα1-6(Manα1-3)Manα1-6)Manβ1-4GlcNAcβ1-

4GlcNAcβ base” and the “N-Glycan complex” is defined as “a glycan chain with a
GlcNAcβ1-2Manα1-3(GlcNAcβ1-2Manα1-6)Manβ1-4GlcNAcβ1-4GlcNAcβ base” In
CFG glycan array version 2.0, the “N-glycan high mannose” motif exists in five glycan
chains: 192, 193, 194, 197, 198 and the “N-Glycan complex” motif also exists in five
glycan chains: 51, 52, 53, 54 and 201 [69]. The glycan chain 201 (Neu5Acα2-3(Galβ13GalNAcβ1-4)Galβ1-4Glcβ-Sp0) does not contain the di-saccharide 3,6Manβ14GlcNAcβ1 and its binding intensity with ConA is low. We then performed similar motif
segregation study to compare the di-saccharide 3,6Manβ1-4GlcNAcβ1 with the “Nglycan high mannose” and “N-Glycan complex” motifs. We used the two-tail unpaired ttest. The p-values are 2.45E-21 for the “N-glycan high mannose” and 1.18E-15 for the
“N-Glycan complex” without counting glycan chain 201. On the other hand, the p-value
for 3,6Manβ1-4GlcNAcβ1 is 4.61E-33. Thus, the di-saccharide 3,6Manβ1-4GlcNAcβ1
may be a better representation of the binding specificity of those 10 glycan chains. We
also identified a significant di-saccharide, Glcα1-4Glcβ, which corresponds to the
terminal glucose motifs identified by motif-based methods [69]. Furthermore, the listing
of glycan chains that contain the significant di-saccharide in Table 5.3 shows that some
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of those significant di-saccharides are dependent of each other. For example, 2Manα13Manα and 3Manα-Sp9 both exist in glycan chains 189 (Manα1-2Manα1-2Manα13Manα-Sp9) and 191 (Manα1-2Manα1-3Manα-Sp9). We may be able to merge them as
a tri-saccharide: 2Manα1-3Manα-Sp9.
Table 5.3 The significant di-saccharide sub-trees binding specifically to ConA.
di-saccharide

Regression
Glycan numbers
Coefficient
Man5-Asn
46769.84
199
α-D-Man-Sp8
46010.46
9
3,6Manα-Sp9
24403.98
190, 195, 196
Glcα1-4Glcβ
20758.13
177
3,6Manβ1-4GlcNAcβ1
18295.47
50, 51, 52, 53, 54, 192, 193, 194, 197, 198
2Manα1-3Manα
17959.44
189, 191
3Manα-Sp9
17959.44
189, 191
Manα1-3,6Manα
16141.64
195, 196
Manα1-3,6Manβ1
10828.64
50, 198
Note: The sub-trees are ordered in descending of coefficients from up to bottom. The
numbers of glycan chains including the significant di-saccharide in CFG glycan array
V2.0 are listed. The regression coefficients are obtained by PLS regression using disaccharide sub trees as features. The glycan numbers are the numbers of glycan chains in
CFG glycan array V2.0.
Table 5.4 The significant di-saccharide sub-trees binding specifically to VVL.
di-saccharide
GalNAcα1-3Galβ
GalNAcβ1-4GlcNAcβ
a-GalNAc-Sp8
b-GalNAc-Sp8
GalNAcβ1-2,3Galβ
GalNAcβ1-3Galα1
Galα1-2,3Galβ
GalNAcα1-2,3Galβ

RegressionCoefficient
47501.78
46390.05
44524.76
44432.05
36068.33
20391.86
-14522
-14717.1
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Glycan numbers
86
92, 93
10
20
89
90
99
84

Note: The sub-trees are ordered in descending of coefficients from up to bottom. The
numbers of glycan chains including the significant di-saccharide in CFG glycan array
V2.0 are listed. The regression coefficients are obtained by PLS regression using disaccharide sub trees as features. The glycan numbers are the numbers of glycan chains in
CFG glycan array V2.0.
Table 5.5 The significant di-saccharide sub-trees binding specifically to WGA.
di-saccharide
Regression Coefficient
Glycan numbers
42672.23
86
GalNAcα1-3Galβ
(6OSO3)GlcNAcβ-Sp8
38904.61
47
GlcNAcβ1-4MDPLys
36691.11
168
GalNAcβ1-3,4GlcNAcβ
35613.5
91
34575.78
121, 159
GlcNAcβ1-3,6GlcNAcα
β-GlcNAc-Sp0
33127.88
21
32604.2
84
GalNAcα1-2,3Galβ
GlcNAcβ1-6Galβ1
31649.8
176
31345.39
10
α-GalNAc-Sp8
β-GlcNAc-Sp8
30441.15
22
GalNAcβ1-4GlcNAcβ
29082.38
92, 93
27593.5
157
GlcNAcα1-6Galβ1
2,3Galβ1-4GlcNAcβ
27091.45
81, 82, 97, 141, 142
Galβ1-4GlcNAcβ
26658.48
152, 153
2Galβ1-4GlcNAcβ1
26061.04
60, 70
GlcNAcβ1-3Galβ1
24471.77
163, 164, 165, 166, 167
-24945.3
77
Fucα1-4GlcNAcβ
-25069.7
112
Galα1-4GlcNAcβ
(6OSO3)Galβ1-4GlcNAcβ
-25093.5
44
KDNa2-3Galβ1
-25176.4
187, 188
Note: The sub-trees are ordered in descending of coefficients from up to bottom. The
numbers of glycan chains including the significant di-saccharide in CFG glycan array
V2.0 are listed. The regression coefficients are obtained by PLS regression using disaccharide sub trees as features. The glycan numbers are the numbers of glycan chains in
CFG glycan array V2.0.
For VVL, we identified six di-saccharide sub-trees with significant positive
regression coefficients (Table 5.4), which included all seven glycan chains with high
binding intensities. All six di-saccharides involved terminal beta-linked GalNAcβ or
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terminal alpha-linked GalNAcα. Previously, terminal beta-linked GalNAcβ was ranked
high by both motif and intensity segregation methods, and terminal alpha-linked
GalNAcα was only ranked high by the intensity segregation method [69]. In the CFG
glycan array version 2.0, there are 10 glycan chains that have terminal alpha-linked
GalNAcα and only two have high binding intensity with VVL. Moreover, there are 13
glycan chains that have terminal beta-linked GalNAcβ in the CFG glycan array version
2.0, and five of them have high binding intensity with VVL. Thus, using only terminal
alpha- and beta- GalNAc to determine the binding specificity of VVL may be
insufficient. When the terminal alpha- and beta- GalNAc are not attached directly to a
spacer in the glycan array, our QSAR results implied that the saccharides attaching to
terminal alpha- and beta-linked GalNAc affect the binding specificity to VVL. For
example, in number 86 (GalNAcα1-3Galβ–Sp8) glycan chain of the CFG glycan array
version 2.0, a terminal GalNAcα attached to a Gal with an α1-3 link and then attached to
the spacer. This glycan chain has high binding intensity. However, when the galactose is
also attached with a fucose, the glycan chain (number 84 (GalNAcα1-3(Fucα1-2)Galβ–
Sp8) of the CFG glycan array version 2.0) loses its binding specificity. The QSAR
method even showed that the GalNAcα1-2,3Galβ has a significant negative coefficient
(Table 5.4). Similarly, a terminal GalNAc attached to a Gal with β1-3 linkage leads to
high binding intensity as in number 89 (GalNAcβ1-3(Fucα1-2)Galβ-Sp8) and number 90
(GalNAcβ1-3Galα1-4Galβ1-4GlcNAcβ-Sp0) glycan chains of the CFG glycan array
version 2.0. However, a terminal GalNAc attached to Gal with β1-4 linkage does not lead
to high binding intensity as in five glycan chains of the CFG glycan array version 2.0:
•

203

(NeuAca2-8NeuAca2-8NeuAca2-8NeuAca2-3(GalNAcb1-4)Galb1-4Glcb-

Sp0)
•

204 (Neu5Aca2-8Neu5Aca2-8Neu5Aca2-3(GalNAcb1-4)Galb1-4Glcb-Sp0)

•

206 (Neu5Aca2-8Neu5Acα2-3(GalNAcβ1-4)Galβ1-4Glcβ–Sp0)

•

209 (Neu5Aca2-3(GalNAcb1-4)Galb1-4GlcNAcb-Sp0)

•

210 (Neu5Aca2-3(GalNAcb1-4)Galb1-4GlcNAcb-Sp8)
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Our results suggested that the binding specificity of VVL needs to be determined
more carefully by considering the saccharides attached to the terminal GalNAc and how
they are attached. This is consistent with the variance explained and R2 results of the PLS
regression study as the PLS regression using di-saccharide sub-trees as features gets
much higher performance. Our results also suggested that visual inspection may not be
able to identify the true binding specificities even for simple glycan array data.
Furthermore, as shown in Table 5.4, each glycan chain contains only one significant disaccharide, which suggests that all significant di-saccharides binding to VVL are
independent.
For WGA, we identified 16 di-saccharide sub-trees with significant positive
regression coefficients and four di-saccharide sub-trees with significant negative
regression coefficient (Table 5.5). The 16 significant di-saccharides exist in 28 glycan
chains of the CFG glycan array version 2.0, which all have high binding intensity with
WGA. All 16 significant di-saccharides of WGA are independent as each glycan chain
contains only one significant di-saccharide. There are three kinds of glycan in those 16
di-saccharides: Gal, GlcNAc and GalNAc. Those 16 di-saccharides cover the “terminal
Lactosamine”, “internal Lactosamine”, “terminal GlcNAcβ”, “Branching”, and “terminal
GalNAcα” motifs identified by motif and intensity segregation methods [69]. However,
one highly ranked motif, “Terminal Neu5Acα2-3Gal”, identified by motif and intensity
segregation methods is missing. We then carefully examined the glycan array data of
WGA. There are 37 glycan chains in CFG glycan array version 2.0 containing the
“Terminal Neu5Acα2-3Gal” motif. The binding intensities of those 37 glycan chains to
WGA are very broad, from -73 to 50264. It is likely that the di-saccharide sub-tree,
“Terminal Neu5Acα2-3Gal”, may not discern the binding specificity of those 37 glycan
chains completely. We then used the tri- and tetra-saccharide sub-trees as features for the
PLS regression. We were able to find one significant tri-saccharide (Neu5Acα2-3Galβ13GlcNAcβ) and four significant tetra-saccharide (Neu5Acα2-3Galβ1-3GlcNAcβ-Sp8,
Neu5Acα2-3Galβ1-4(6OSO3)GlcNAcβ-Sp8,

Neu5Acα2-3Galβ1-4GlcNAcβ-Sp0,

Neu5Acα2-3Galβ1-4GlcNAcβ-Sp8) that contain terminal Neu5Acα2-3Gal. The results
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implied that the terminal Neu5Acα2-3Gal may need to attach to a GlcNAc to make the
binding to WGA more specific.

5.2.4 Evaluation of QSAR Model on Other Glycan-binding Proteins
To further demonstrate the effectiveness of the QSAR method, we tested it on
several glycan-binding proteins. We first apply the QSAR to glycan array data of two
plant lectins: Peanut Agglutinin (PNA) and Sambucus Nigra Lectin (SNA). For PNA, the
PLS regressions using di-saccharide and tri-saccharide sub-trees as features can obtain
significant high R2 of 0.9603 and 0.9966 respectively (Table 5.1). We used PLS-Beta
method to identify 11 tri-saccharide sub-trees with significant positive regression
coefficients and three tri-saccharide sub-trees with significant negative regression
coefficients (Table 5.6). Our results showed that PNA have high binding affinities with
the terminal Galβ1–3GalNAc, which is consistent with previous study [73]. However, if
there are other glycan attached to N-acetylgalactosamine (GalNAc) or the Galβ1–
3GalNAc is directly attached to spacer arm (SP), the binding intensity of Galβ1–
3GalNAc is reduced. We also observed that terminal galactose attached to another
galactose with a β1-3 link also have high binding intensity. Furthermore, non-terminal
Galβ1–3GalNAc has low binding affinity and leads to the negative coefficients. For
SNA, the PLS regressions using di-saccharide sub-trees as features can obtain significant
high R2 of 0.9085 Table 5.1). As shown in Table 5.7, the PLS-Beta method successfully
identified that SNA have high binding affinities with α2–6-linked N-Glycolylneuraminic
Acid (Neu5Gcα2-6) bound to galactose (Gal) or N-acetylgalactosamine (GalNAc) [74].
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Table 5.6 The significant tri-saccharide sub-trees binding specifically to PNA.
tri-saccharide
Regression Coefficient
Glycan numbers
50301.69
125
(Galβ1-3)-3GalNAcα-Sp8
(Galβ1-3)-3GalNAcβ-Sp8
49878.81
126
(Galβ1-3)-3Galβ-Sp8
47607.33
130
29692.31
120,
121,
122, 123
(Galβ1-3)-3,6GlcNAcα-Sp8
(Galβ1-3)-(3GalNAcβ1-4)-3,4Galβ1
28104.38
128, 201
27781.27
150, 174, 241, 256
(Galβ1-3)-3,6GalNAcα-Sp8
23494.39
127
(Galβ1-3)-(3GalNAcβ1-3)-3Galα1
(3GalNAcβ1-4)-(4Galβ1-4)-4Glcβ
15204.52
129
(4Galβ1-4)-4Glcβ-Sp8
15204.52
129
(Galβ1-3)-(3GalNAcβ1-4)-4Galβ1
15204.52
129
13740.78
241
(Galβ1-3)(Neu5Acα-6)-3,6GalNAcα
-12988.4
223
(3Galβ1-3)-(3GalNAcβ1-3)-3Galα1
(2Galβ1-3)-(3GalNAcβ1-4)-3,4Galβ1
-13998.6
59, 60
(Neu5Acα2-3)-(3Galβ1-3)-19045.3
212, 223
3GalNAcβ1
Note: The sub-trees are ordered in descending of coefficients from up to bottom. The
numbers of glycan chains including the significant tri-saccharide in CFG glycan array
V2.0 are listed. The regression coefficients are obtained by PLS regression using trisaccharide sub trees as features. The glycan numbers are the numbers of glycan chains in
CFG glycan array V2.0.
Table 5.7 The significant di-saccharide sub-trees binding specifically to SNA.
di-saccharide
(Neu5Gcα2-6)-6Galβ1
(9NAcNeu5Acα2-6)-6Galβ1
(Neu5Acα2-6)-6Galβ1

Regression Coefficient
33419.7
29606.3

Glycan numbers
263
49
53, 54, 244, 245, 246,
27618.6
247, 248, 249, 250
(Neu5Acα2-6)-6Galβ
21657.7
251
(Neu5Acα2-6)-6GalNAcβ1
19823.3
243
(6GalNAcβ1-4)-4GlcNAcβ
19823.3
243
Note: The sub-trees are ordered in descending of coefficients from up to bottom. The
numbers of glycan chains including the significant di-saccharide in CFG glycan array
V2.0 are listed. The regression coefficients are obtained by PLS regression using di-
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saccharide sub trees as features. The glycan numbers are the numbers of glycan chains in
CFG glycan array V2.0.
Then, we tested the QSAR method on the glycan array data of two animal lectins:
sialic acid binding immunoglobulin-like lectin 8 (Siglec-8) and dendritic cell specific
ICAM-3 grabbing non-integrin (DC-SIGN). For DC-SIGN, both PLS regression using disaccharide and tri-saccharide sub-trees as features obtained significant high R2 of 0.9179
and 0.9533 respectively (Table 5.1). The PLS-Beta method identified 22 tri-saccharide
sub-trees with significant regression coefficients (Table 5.8). The top tri-saccharide,
(Fucα1-3)(2Galβ1-4)-3,4GlcNAcβ (LeX) is known to bind with DC-SIGN [75]. However,
there is no mannose in our identified tri-saccharides. This may be because glycans
containing mannose have both high and low binding intensities. For example, glycan
chain

197

(Manα1-6(Manα1-3)Manα1-6(Manα1-2Manα1-3)Manβ1-4GlcNAcβ1-

4GlcNAcβ-Asn) and glycan chain 198 (Manα1-6(Manα1-3)Manα1-6(Manα1-3)Manβ14GlcNAcβ1-4GlcNAcβ-Asn) in CFG glycan array V2.1 have similar structure. The
glycan chain 197 is decomposed into 9 tri-saccharide sub-trees and glycan chain 198 is
decomposed into 8 tri-saccharide sub-trees. Among them, six tri-saccharide sub-trees are
the same. However, glycan chain 197 has a binding intensity of 6358.993 with DG-SIGN
and glycan chain 198 have a binding intensity of 186.303 with DG-SIGN. For Siglec-8,
PLS regression using all four types of sub-trees as features can obtain significant high
R2>0.99 (Table 5.1). The PLS-Beta method successfully identified the sialylated-sulfated
galactose as the specific binding motif of Siglec-8 (Table 5.9).
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Table 5.8 The significant tri-saccharide sub-trees binding specifically to DC-SIGN.
tri-saccharide

Regression Coefficient

(Fucα1-3)(2Galβ1-4)-3,4GlcNAcβ
4918.172
(Fucα1-2)-(2Galβ1-4)-3,4GlcNAcβ
4918.172
((3OSO3)Galβ1-4)-4(6OSO3)Glcβ-Sp0
4891.928
(GalNAcα1-3)-3GalNAcβ-Sp8
4706.763
(GlcNAcβ1-3)-(3Galβ1-4)-4GlcNAcβ1
4336.227
(3,4GalNAcβ1-3)-(3Galβ1-4)4287.536
3,4GlcNAcβ
(2Galβ1-4)-3,4GlcNAcβ-Sp0
4044.822
((3OSO3)Galβ1-4)-4Glcβ-Sp8
4011.979
(3,4GlcNAcβ1-4)-(4Galβ1-4)3993.198
3,4GlcNAcβ1
(4Galβ1-4)-(3,4GlcNAcβ1-4)-4Galβ1
3993.198
(Fucα1-3)(4Galβ1-4)-3,4GlcNAcβ1
3993.198
(Galβ1-4)-3,4GlcNAcβ-Sp8
3947.659
(KDNa2-3)-(3Galβ1-4)-4GlcNAcβ
3605.753
(4Galβ1-4)-4GlcNAcβ-Sp8
3303.441
(GlcNAcβ1-4)-(4Galβ1-4)-4GlcNAcβ
3303.441
(2Galβ1-4)-(3,4GalNAcβ1-3)-3Galβ1
3135.134
(Fucα1-2)-(2Galβ1-4)-3,4GalNAcβ1
3135.134
(Fucα1-3)(2Galβ1-4)-3,4GalNAcβ1
3135.134
(Fucα1-3)-(3,4GalNAcβ1-3)-3Galβ1
3135.134
(Fucα1-4)-3,4GlcNAc-Sp8
3036.607
(Galβ1-3)-3,4GlcNAc-Sp8
3036.607
(Fucα1-2)-2Galβ-Sp8
2947.905
Note: The sub-trees are ordered in descending of coefficients from up

Glycan
numbers
67, 68
67, 68
29
85
166
65
67
28
138
138
138
136
188
170
170
65, 66
65, 66
65, 66
65, 66
118
118
74
to bottom. The

numbers of glycan chains including the significant tri-saccharide in CFG glycan array
V2.1 are listed. The regression coefficients are obtained by PLS regression using trisaccharide sub trees as features. The glycan numbers are the numbers of glycan chains in
CFG glycan array V2.1.
Table 5.9 The significant mono-saccharide sub-trees binding specifically to Siglec-8.
mono-saccharide
3(6OSO3)Galβ1
3(6-O-Su)Galβ1

Regression Coefficient
8655.456
7816.967
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Glycan numbers
246
354

Note: The sub-trees are ordered in descending of coefficients from up to bottom. The
numbers of glycan chains including the significant mono-saccharide in CFG glycan array
V4.1 are listed. The regression coefficients are obtained by PLS regression using monosaccharide sub trees as features. The glycan numbers are the numbers of glycan chains in
CFG glycan array V4.1.
Finally, we tested the QSAR method on the glycan array data of two antibodies:
CSLEX1 (human CD15s antibody) and Sialyl Lewis x antibody (CD15s) - 10. For both
antibodies, the PLS regression using tetra-saccharide sub-trees as features obtained the
highest R2>0.99 (Table 5.10). For CSLEX1, the PLS-Beta method successfully identified
the Sialy1 Lewis x, ((Neu5Acα2-3)-3Galβ1-4)(Fucα1-3)-3,4GlcNAcβ1, as the most
significant tetra-saccharide sub-tree (Table 5.11). Meanwhile, the results showed that the
glycan chain of (Neu5Acα2-3)-(3(6OSO3)Galβ1-4)-4GlcNAcβ also have binding affinity
to the CSLEX1. For Sialyl Lewis x antibody (CD15s) - 10, the Sialy1 Lewis x,
((Neu5Acα2-3)-3Galβ1-4)(Fucα1-3)-3,4GlcNAcβ1, is also among the top significant
tetra-saccharide sub-trees (Table 5.12). It is not the most significant sub-tree because two
glycan

chains

6)GalNAcα-Sp14)

(number
and

297
377

(Galβ1-3(Neu5Acα2-3Galβ1-4(Fucα1-3)GlcNAcβ1(Neu5Acα2-3Galβ1-4(Fucα1-3)GlcNAcβ1-3GalNAcα-

Sp14)) containing the Sialyl Lewis x structure have very low binding intensities. As
shown in Table 5.12, the PLS regression assigned two other tetra-saccharide sub-trees
[(3Galβ1-4)(Fucα1-3)-(3,4GlcNAcβ1-3)-3GalNAcα,

(3Galβ1-4)-(3,4GlcNAcβ1-3)-

3GalNAcα-Sp14] in glycan chain 377 with high negative coefficients in order to balance
the high regression coefficient of Sialyl Lewis x. These results implied that the binding
intensities of a Sialyl Lewis x are reduced if it is attached to an N-acetylgalactosamine.
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Table 5.10 The R2 of PLS regressions on glycan array data of different antibodies using
different features.
Mono
Di
CSLEX1 (human CD15s antibody)
0.3954
0.6362
Sialyl Lewis x antibody-10
0.1374
0.5147
Note: The highest values of R squares are highlighted in bold.

Tri
0.983
0.9463

Tetra
0.9952
0.9949

Table 5.11 The significant tetra-saccharide sub-trees binding specifically to CSLEX1
(human CD15s antibody).
tetra-saccharide

Regression
Coefficient

((Neu5Acα2-3)-3Galβ1-4)(Fucα1-3)-3,4GlcNAcβ1

11142.85

Glycan
numbers
242, 245,
246, 290,
332, 374
43
243, 244
242

(Neu5Acα2-3)-(3(6OSO3)Galβ1-4)-4GlcNAcβ-Sp8
9937.952
((Neu5Acα2-3)-3Galβ1-4)(Fucα1-3)-3,4GlcNAcβ
9304.732
(3Galb1-4)-(3,4GlcNAcβ1-3)-(3Galβ1-4)8146.454
3,4GlcNAcβ1
((Neu5Acα2-3)-3(6-O-Su)Galb1-4)(Fucα1-3)8145.086
220
3,4GlcNAcβ
(Fucα1-3)(3(6-O-Su)Galβ1-4)-3,4GlcNAcβ-Sp8
8145.086
220
(Neu5Acα2-3)-(3(6-O-Su)Galβ1-4)-3,4GlcNAcβ-Sp8
8145.086
220
Note: The sub-trees are ordered in descending of coefficients from up to bottom. The
numbers of glycan chains including the significant tetra-saccharide in CFG glycan array
V4.0 are listed. The regression coefficients are obtained by PLS regression using tetrasaccharide sub trees as features. The glycan numbers are the numbers of glycan chains in
CFG glycan array V4.0.
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Table 5.12 The significant tetra-saccharide sub-trees binding specifically to Sialyl Lewis
x antibody-10.
Regression
Coefficient

tetra-saccharide

Glycan numbers

(3Galβ1-4)-(3,4GlcNAcβ1-3)-(3Galβ1-4)1551.394
251
3,4GlcNAcβ1
((Neu5Acα2-3)-3Galβ1-4)(Fucα1-3)251, 254, 255, 297,
1424.837
3,4GlcNAcβ1
377
(3Galβ1-4)(Fucα1-3)-(3,4GlcNAcβ1-3)863.0468
254
3Galβ
(3Galβ1-4)-(3,4GlcNAcβ1-3)-3Galβ-Sp8
863.0468
254
(Fucα1-3)-(3,4GlcNAcβ1-3)-3Galβ-Sp8
863.0468
254
((3,4GlcNAcβ1-3)-3Galβ1-4)(Fucα1-3)654.8089
70, 251
3,4GlcNAcβ1
(Fucα1-3)-(3,4GlcNAcβ1-3)-(3Galβ1-4)654.8089
70, 251
3,4GlcNAcβ1
(3Galβ1-4)(Fucα1-3)-(3,4GlcNAcβ1-3)-581.447
377
3GalNAcα
(3Galβ1-4)-(3,4GlcNAcβ1-3)-3GalNAcα-581.447
377
Sp14
(2Galβ1-4)(Fucα1-3)-(3,4GlcNAcβ1-3)-702.1
69, 70
3Galβ1
(2Galβ1-4)-(3,4GlcNAcβ1-3)-(3Galβ1-4)-896.585
70
3,4GlcNAcβ1
Note: The sub-trees are ordered in descending of coefficients from up to bottom. The
numbers of glycan chains including the significant tetra-saccharide in CFG glycan array
V4.1 are listed. The regression coefficients are obtained by PLS regression using tetrasaccharide sub trees as features. The glycan numbers are the numbers of glycan chains in
CFG glycan array V4.1.

5.3 Discussion
The application of glycan array is impeded currently by the lack of automatic and
systematic methods to extract useful information [69]. In this study, we proposed a novel
quantitative structure-activity relationship (QSAR) method to address this need. We first
automatically decomposed the glycan chains into sub-trees. Then, we applied PLS
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regression to the glycan array data using sub-trees as features. Based on PLS regression,
we were able to identify significant sub-tees that contribute to binding. We demonstrated
our methods on glycan array data of multiple glycan binding proteins. Moreover, the substructure features are generated automatically. We also developed a user-friendly web
tool that can facilitate the rapid and automatic analysis of glycan array data.
Compared with predefined motifs, automatic decomposition of glycan chains into
sub structures provides much broader features for selecting binding specificity. For
example, in glycan array data of VVL, terminal alpha-linked GalNAc exists in glycan
chains with both high and low binding intensities. Simply using terminal alpha-linked
GalNAc as a feature to determine the binding specificity is insufficient. Actually, the
motif segregation methods did not rank terminal alpha-linked GalNAc high. Meanwhile,
by using di-saccharide sub-trees as features, our QSAR method successfully identified
binding specific di-saccharides that include terminal alpha-linked GalNAc. Our results
implied that the saccharide attached to terminal alpha-linked GalNAc also determined the
binding specificity of VVL. Furthermore, the bindings of glycan chains to proteins are
complex. Fixed features, like predefined motifs, may not be able to identify real binding
specificity. For example, the QSAR method identified that a di-saccharide: 3,6Manβ14GlcNAcβ1, contributed to binding of ConA. This di-saccharide is a subset of both “Nglycan high mannose” and “N-Glycan complex” motifs. Further analysis showed that the
3,6Manβ1-4GlcNAcβ1 has a lower p-value based on motif segregation. Thus, the
3,6Manβ1-4GlcNAcβ1 may be the real contributor to the binding specificity of ConA.
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Further experiments are needed to confirm the conclusion. But the QSAR method
showed the potential to determine more representative binding specificities.
Both motif and intensity segregation methods need to separate the glycan data
into two groups and then select the significant motif based on statistical tests on the
intensities of the two groups. For intensity segregation, a threshold is needed to determine
high and low intensities, which will bring uncertainty to the results [69]. Meanwhile, as
the number of glycan chains containing a certain motif is low, the motif segregation
suffers from unbalanced data in the two groups [69]. Our QSAR method overcomes the
uncertainty and bias as it does not need to separate the glycan data into two groups as
motif and intensity segregation methods.
Currently, we performed the PLS regression using different size sub-trees
separately. Our current approach fixed the size of sub-structures to represent binding
specificity. However, glycan-binding proteins may bind to different size sub-trees in
glycan chains. For example, we showed that some di-saccharides of ConA are correlated
and may be merged to tri-saccharide sub-trees. In the future, we will further develop the
QSAR methods using all sub-trees under a certain size as features. However, directly
using all sub-trees will lead to overfitting as features overlap. We are currently exploring
feature selection methods to remove overlapped features. Then, the PLS regression will
be performed on selected features.
In conclusion, our QSAR method provides a new tool for efficient analysis of
glycan array data. Our method is general and can be applied to different types of glycan
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array of different glycan-binding proteins. Our method should prompt the utilization of
glycan array and help understand the biology of glycan-binding proteins.
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Chapter 6
Conclusion and Future Work
In this thesis, we present a data-intensive computing platform for bioinformatics
applications using virtualization technologies and HPC infrastructures. The platform
seamlessly integrates the web user interface (presentation tier), scientific workflow (logic
tier) and computing infrastructure (data/computing tier).
This platform is demonstrated through two bioinformatics projects. At first
project, we redesigned and deployed CMD website using the Xen-based virtualization
solution. Now CMD is a centralized web portal in the cotton research community. To
achieve high-performance and scalability for CMD web tools, we hosted the large
amounts of protein databases and computational intensive applications of CMD on the
Palmetto HPC of Clemson University. Biologists can easily utilize both bioinformatics
applications and HPC resources through the CMD website even with little background in
computer science. Since 2009, CMD has been accessed by users from 101 countries all
over the world and 48 states in USA. Currently, CMD project hosts 18 projects with
17,448 publicly available SSRs, 312 mapped cotton RFLP sequences containing SSRs
and 27 genetic maps for Gossypium genomics.
Second, a web tool, Glycan Array QSAR Tool, was developed on our
bioinformatics platform to analyze glycan array data. The user interface of this tool was
developed at the top of Drupal Content Management Systems (CMS) and the
computational part was implemented using MATLAB Compiler Runtime (MCR)
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module. This QSAR method is general and can be applied to different types of glycan
array of different glycan-binding proteins, and it should prompt the utilization of glycan
array and help understanding the biology of glycan-binding proteins.
In conclusion, our new bioinformatics computing platform enables the rapid
deployment of data-intensive bioinformatics applications using an HPC and virtualization
environment with a user-friendly web interface and bridges the gap between biological
scientists and cyberinfrastructure.
Some bioinformatics applications require specific computing environments,
which are not provided by public computing infrastructures. For example, applications
need a specific resource management system which is different with current HPC
resources (e.g. SGE, Hadoop scheduler); prerequisite libraries or compliers conflict with
its version in the current Operation System; the I/O access pattern does not match the
storage system of HPC (e.g. Hadoop HDFS needs the shared-nothing file system). To
overcome all difficulties related to the deployments of bioinformatics application on
computing environment, our current solution is to port all those bioinformatics
applications on the private computing infrastructures (e.g. remote private Linux cluster,
local web server). However, for the larger-scale applications, the public HPC (e.g.
Clemson Palmetto HPC) is the only feasible infrastructure which could provide sufficient
computing resource. In our future research, we plan to extend the current virtualization
solution from server virtualization to computing infrastructure virtualization. We will
construct a virtual HPC cluster at the top of the public computing infrastructures, and
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finally deploy all bioinformatics applications on public HPC or Cloud platforms. This
new solution can bring many advantages:
-

Improve the scalability of bioinformatics applications.

-

Increase the flexibility of deployment and reduce the complexity of
bioinformatics platform.

-

Improve the reliability of whole system.

-

Enhance the security of whole system
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Appendix A
Table A-I. CFG array v2.0 mono-saccharide Features Summary
Number of Feature
0
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42

mono-saccharide
(3OSO3)(6OSO3)Galb1
(3OSO3)Galb
(3OSO3)Galb1
(4OSO3)(6OSO3)Galb1
(4OSO3)Galb1
(6H2PO3)Mana
(6OSO3)Galb1
(6OSO3)GlcNAcb
2,3Galb
2,3Galb1
2,4Galb1
2Galb
2Galb1
2GlcNAcb
2Mana1
3(6-O-Su)Galb1
3(6OSO3)GalNAca
3(6OSO3)Galb1
3(6OSO3)GlcNAcb
3,4(6OSO3)GlcNAcb
3,4,6GlcNAc
3,4GalNAcb
3,4GalNAcb1
3,4Galb1
3,4GlcNAc
3,4GlcNAcb
3,4GlcNAcb1
3,6GalNAca
3,6GalNAcb
3,6Galb1
3,6GlcNAca
3,6GlcNAcb1
3,6Mana
3,6Mana1
3,6Manb1
3GalNAca
3GalNAcb
3GalNAcb1
3Gala
3Gala1
3Galb
3Galb1
3GlcNAca
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43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
61
62
63
64
65
66
67
68
69
70
71
72
73
74
75
76
77
78
79
80
81
82
83
84
85
86
87
88
89
90
91

3GlcNAcb
3GlcNAcb1
3Mana
4(6OSO3)GlcNAcb
4(6OSO3)Glcb
4,6GalNAca
4GalNAca1
4GalNAcb
4GalNAcb1
4Galb
4Galb1
4GlcNAcb
4GlcNAcb1
4Glca
4Glcb
4MDPLys
6GalNAca
6GalNAcb1
6Galb
6Galb1
6Glca1
6Glcb
8Neu5Aca
8Neu5Aca2
9NAcNeu5Aca
9NAcNeu5Aca2
Asn
Fuca1
Fucb1
GalNAca1
GalNAcb1
Gala1
Galb1
GlcAa
GlcAb
GlcAb1
GlcNAca1
GlcNAcb1
Glca1
Glcb1
Gly
KDNa2
Man5
Mana1
Manb1
Neu5Aca
Neu5Aca2
Neu5Acb2
Neu5Gca
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92
93
94
95
96
97
98
99
100
101
102
103
104
105
106
107
108
109
110
111

Neu5Gca2
Sp0
Sp10
Sp11
Sp8
Sp9
a-D-Gal
a-D-Glc
a-D-Man
a-GalNAc
a-L-Fuc
a-L-Rha
a-NeuAc
b-D-Gal
b-D-Glc
b-D-Man
b-GalNAc
b-GlcN(Gc)
b-GlcNAc
b-NeuAc
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Table A-II. CFG array v2.0 di-saccharide Features Summary
Number of Feature
0
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46

di-saccharide
((3OSO3)(6OSO3)Galb1-4)-4(6OSO3)GlcNAcb
((3OSO3)(6OSO3)Galb1-4)-4GlcNAcb
((3OSO3)Galb1-3)-3,4GlcNAcb
((3OSO3)Galb1-3)-3GalNAca
((3OSO3)Galb1-3)-3GlcNAcb
((3OSO3)Galb1-4)-3,4GlcNAcb
((3OSO3)Galb1-4)-4(6OSO3)GlcNAcb
((3OSO3)Galb1-4)-4(6OSO3)Glcb
((3OSO3)Galb1-4)-4GlcNAcb
((3OSO3)Galb1-4)-4Glcb
((4OSO3)(6OSO3)Galb1-4)-4GlcNAcb
((4OSO3)Galb1-4)-4GlcNAcb
((6OSO3)Galb1-4)-4(6OSO3)Glcb
((6OSO3)Galb1-4)-4GlcNAcb
((6OSO3)Galb1-4)-4Glcb
(2,3Galb1-3)-3GlcNAcb
(2,3Galb1-4)-3,4GlcNAcb
(2,3Galb1-4)-4GlcNAcb
(2,3Galb1-4)-4Glcb
(2,4Galb1-4)-4GalNAcb
(2,4Galb1-4)-4GlcNAcb
(2Galb1-3)-3,4GlcNAcb
(2Galb1-3)-3GalNAca
(2Galb1-3)-3GalNAcb
(2Galb1-3)-3GalNAcb1
(2Galb1-3)-3GlcNAca
(2Galb1-4)-3,4GalNAcb1
(2Galb1-4)-3,4GlcNAcb
(2Galb1-4)-4GlcNAcb
(2Galb1-4)-4GlcNAcb1
(2Galb1-4)-4Glcb
(2Mana1-2)-2Mana1
(2Mana1-3)-3,6Mana
(2Mana1-3)-3,6Mana1
(2Mana1-3)-3,6Manb1
(2Mana1-3)-3Mana
(2Mana1-6)-3,6Mana
(2Mana1-6)-3,6Mana1
(2Mana1-6)-3,6Manb1
(3(6-O-Su)Galb1-4)-3,4GlcNAcb
(3(6OSO3)Galb1-4)-4GlcNAcb
(3,4GalNAcb1-3)-3Galb1
(3,4Galb1-4)-4GlcNAcb
(3,4Galb1-4)-4Glcb
(3,4GlcNAcb1-3)-3Galb
(3,4GlcNAcb1-3)-3Galb1
(3,4GlcNAcb1-4)-4Galb1
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47
48
49
50
51
52
53
54
55
56
57
58
59
60
61
62
63
64
65
66
67
68
69
70
71
72
73
74
75
76
77
78
79
80
81
82
83
84
85
86
87
88
89
90
91
92
93
94
95

(3,6Galb1-4)-4GlcNAcb
(3,6GlcNAcb1-4)-4Galb1
(3,6Mana1-6)-3,6Manb1
(3,6Manb1-4)-4GlcNAcb1
(3GalNAcb1-3)-3Gala
(3GalNAcb1-3)-3Gala1
(3GalNAcb1-3)-3Galb1
(3GalNAcb1-4)-3,4Galb1
(3GalNAcb1-4)-4Galb1
(3GalNAcb1-4)-4GlcNAcb
(3Gala1-4)-4Galb1
(3Galb1-3)-3(6OSO3)GalNAca
(3Galb1-3)-3(6OSO3)GlcNAcb
(3Galb1-3)-3,4GlcNAcb
(3Galb1-3)-3,4GlcNAcb1
(3Galb1-3)-3,6GalNAcb
(3Galb1-3)-3GalNAca
(3Galb1-3)-3GalNAcb1
(3Galb1-3)-3GlcNAcb
(3Galb1-3)-3GlcNAcb1
(3Galb1-4)-3,4(6OSO3)GlcNAcb
(3Galb1-4)-3,4GalNAcb
(3Galb1-4)-3,4GlcNAcb
(3Galb1-4)-3,4GlcNAcb1
(3Galb1-4)-4(6OSO3)GlcNAcb
(3Galb1-4)-4GlcNAcb
(3Galb1-4)-4GlcNAcb1
(3Galb1-4)-4Glcb
(3GlcNAcb1-3)-3Galb1
(3OSO3)Galb-Sp8
(4GalNAca1-3)-2,3Galb1
(4GalNAcb1-3)-2,3Galb1
(4Galb1-4)-3,4GlcNAcb
(4Galb1-4)-3,4GlcNAcb1
(4Galb1-4)-4GalNAcb
(4Galb1-4)-4Galb
(4Galb1-4)-4GlcNAcb
(4Galb1-4)-4Glca
(4Galb1-4)-4Glcb
(4GlcNAcb1-2)-2Mana1
(4GlcNAcb1-3)-3,6GalNAca
(4GlcNAcb1-3)-3GalNAca
(4GlcNAcb1-3)-3Galb1
(4GlcNAcb1-4)-4GlcNAcb
(4GlcNAcb1-6)-3,6GalNAca
(4GlcNAcb1-6)-3,6GlcNAca
(4GlcNAcb1-6)-6GalNAca
(6GalNAcb1-4)-4GlcNAcb
(6Galb1-4)-4(6OSO3)GlcNAcb
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96
97
98
99
100
101
102
103
104
105
106
107
108
109
110
111
112
113
114
115
116
117
118
119
120
121
122
123
124
125
126
127
128
129
130
131
132
133
134
135
136
137
138
139
140
141
142
143
144

(6Galb1-4)-4GlcNAcb
(6Galb1-4)-4GlcNAcb1
(6Galb1-4)-4Glcb
(6Glca1-6)-6Glcb
(6H2PO3)Mana-Sp8
(6OSO3)GlcNAcb-Sp8
(8Neu5Aca2-3)-3,4Galb1
(8Neu5Aca2-3)-3Galb1
(8Neu5Aca2-8)-8Neu5Aca
(8Neu5Aca2-8)-8Neu5Aca2
(9NAcNeu5Aca2-6)-6Galb1
(Fuca1-2)-2,3Galb
(Fuca1-2)-2,3Galb1
(Fuca1-2)-2,4Galb1
(Fuca1-2)-2Galb
(Fuca1-2)-2Galb1
(Fuca1-2)-2GlcNAcb
(Fuca1-3)-3,4(6OSO3)GlcNAcb
(Fuca1-3)-3,4GalNAcb
(Fuca1-3)-3,4GalNAcb1
(Fuca1-3)-3,4GlcNAcb
(Fuca1-3)-3,4GlcNAcb1
(Fuca1-3)-3GlcNAcb
(Fuca1-4)-3,4GlcNAc
(Fuca1-4)-3,4GlcNAcb
(Fuca1-4)-3,4GlcNAcb1
(Fuca1-4)-4GlcNAcb
(Fucb1-3)-3GlcNAcb
(GalNAca1-3)-2,3Galb
(GalNAca1-3)-2,3Galb1
(GalNAca1-3)-3GalNAca
(GalNAca1-3)-3GalNAcb
(GalNAca1-3)-3Galb
(GalNAca1-4)-2,4Galb1
(GalNAcb1-3)-2,3Galb
(GalNAcb1-3)-3Gala1
(GalNAcb1-4)-3,4Galb1
(GalNAcb1-4)-3,4GlcNAcb
(GalNAcb1-4)-4GlcNAcb
(Gala1-2)-2Galb
(Gala1-3)-2,3Galb
(Gala1-3)-2,3Galb1
(Gala1-3)-3,4Galb1
(Gala1-3)-3Galb
(Gala1-3)-3Galb1
(Gala1-3)-3GlcNAca
(Gala1-3)-3GlcNAcb
(Gala1-4)-2,4Galb1
(Gala1-4)-3,4Galb1
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145
146
147
148
149
150
151
152
153
154
155
156
157
158
159
160
161
162
163
164
165
166
167
168
169
170
171
172
173
174
175
176
177
178
179
180
181
182
183
184
185
186
187
188
189
190
191
192
193

(Gala1-4)-4Galb1
(Gala1-4)-4GlcNAcb
(Gala1-6)-6Glcb
(Galb1-2)-2Galb
(Galb1-3)-3,4GlcNAc
(Galb1-3)-3,4GlcNAcb
(Galb1-3)-3,4GlcNAcb1
(Galb1-3)-3,6GalNAca
(Galb1-3)-3,6GlcNAca
(Galb1-3)-3,6GlcNAcb1
(Galb1-3)-3GalNAca
(Galb1-3)-3GalNAcb
(Galb1-3)-3GalNAcb1
(Galb1-3)-3Galb
(Galb1-3)-3GlcNAcb
(Galb1-4)-3,4GlcNAcb
(Galb1-4)-3,4GlcNAcb1
(Galb1-4)-4(6OSO3)Glcb
(Galb1-4)-4GalNAca1
(Galb1-4)-4GalNAcb1
(Galb1-4)-4GlcNAcb
(Galb1-4)-4GlcNAcb1
(Galb1-4)-4Glcb
(GlcAb1-3)-3Galb
(GlcAb1-6)-6Galb
(GlcNAca1-3)-3Galb1
(GlcNAca1-6)-6Galb1
(GlcNAcb1-2)-2Galb1
(GlcNAcb1-2)-2Mana1
(GlcNAcb1-3)-3,4,6GlcNAc
(GlcNAcb1-3)-3,6Galb1
(GlcNAcb1-3)-3,6GlcNAca
(GlcNAcb1-3)-3GalNAca
(GlcNAcb1-3)-3Galb
(GlcNAcb1-3)-3Galb1
(GlcNAcb1-4)-3,4,6GlcNAc
(GlcNAcb1-4)-4,6GalNAca
(GlcNAcb1-4)-4Galb1
(GlcNAcb1-4)-4GlcNAcb1
(GlcNAcb1-6)-3,4,6GlcNAc
(GlcNAcb1-6)-3,6GalNAca
(GlcNAcb1-6)-3,6Galb1
(GlcNAcb1-6)-3,6GlcNAca
(GlcNAcb1-6)-4,6GalNAca
(GlcNAcb1-6)-6GalNAca
(GlcNAcb1-6)-6Galb1
(Glca1-4)-4Glca
(Glca1-4)-4Glcb
(Glca1-6)-6Glca1
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194
195
196
197
198
199
200
201
202
203
204
205
206
207
208
209
210
211
212
213
214
215
216
217
218
219
220
221
222
223
224
225
226
227
228
229
230
231
232
233
234
235
236
237
238
239
240
241
242

(Glcb1-4)-4Glcb
(Glcb1-6)-6Glcb
(KDNa2-3)-3Galb1
(Mana1-2)-2Mana1
(Mana1-3)-3,6Mana
(Mana1-3)-3,6Mana1
(Mana1-3)-3,6Manb1
(Mana1-6)-3,6Mana
(Mana1-6)-3,6Mana1
(Mana1-6)-3,6Manb1
(Manb1-4)-4GlcNAcb
(Neu5Aca2-3)-3(6-O-Su)Galb1
(Neu5Aca2-3)-3(6OSO3)Galb1
(Neu5Aca2-3)-3,4Galb1
(Neu5Aca2-3)-3,6GalNAca
(Neu5Aca2-3)-3GalNAca
(Neu5Aca2-3)-3GalNAcb1
(Neu5Aca2-3)-3Galb
(Neu5Aca2-3)-3Galb1
(Neu5Aca2-6)-3,6GalNAca
(Neu5Aca2-6)-3,6GalNAcb
(Neu5Aca2-6)-3,6GlcNAca
(Neu5Aca2-6)-3,6GlcNAcb1
(Neu5Aca2-6)-6GalNAca
(Neu5Aca2-6)-6GalNAcb1
(Neu5Aca2-6)-6Galb
(Neu5Aca2-6)-6Galb1
(Neu5Aca2-8)-8Neu5Aca
(Neu5Aca2-8)-8Neu5Aca2
(Neu5Acb2-6)-3,6GalNAca
(Neu5Acb2-6)-3,6GlcNAca
(Neu5Acb2-6)-6GalNAca
(Neu5Acb2-6)-6Galb1
(Neu5Gca2-3)-3Galb1
(Neu5Gca2-6)-6GalNAca
(Neu5Gca2-6)-6Galb1
2,3Galb-Sp8
2Galb-Sp8
2GlcNAcb-Sp8
3(6OSO3)GalNAca-Sp8
3(6OSO3)GlcNAcb-Sp8
3,4(6OSO3)GlcNAcb-Sp8
3,4,6GlcNAc-Sp8
3,4GalNAcb-Sp0
3,4GalNAcb-Sp8
3,4GlcNAc-Sp0
3,4GlcNAc-Sp8
3,4GlcNAcb-Sp0
3,4GlcNAcb-Sp8
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243
244
245
246
247
248
249
250
251
252
253
254
255
256
257
258
259
260
261
262
263
264
265
266
267
268
269
270
271
272
273
274
275
276
277
278
279
280
281
282
283
284
285
286
287
288
289
290
291

3,6GalNAca-Sp8
3,6GalNAcb-Sp8
3,6GlcNAca-Sp8
3,6Mana-Sp9
3GalNAca-Sp8
3GalNAcb-Sp0
3GalNAcb-Sp8
3Gala-Sp9
3Galb-Sp8
3GlcNAca-Sp8
3GlcNAcb-Sp0
3GlcNAcb-Sp8
3Mana-Sp9
4(6OSO3)GlcNAcb-Sp0
4(6OSO3)GlcNAcb-Sp8
4(6OSO3)Glcb-Sp0
4(6OSO3)Glcb-Sp8
4,6GalNAca-Sp8
4GalNAcb-Sp0
4GalNAcb-Sp8
4Galb-Sp0
4GlcNAcb-Asn
4GlcNAcb-Gly
4GlcNAcb-Sp0
4GlcNAcb-Sp8
4GlcNAcb1-Sp8
4Glca-Sp8
4Glca-Sp9
4Glcb-Sp0
4Glcb-Sp10
4Glcb-Sp8
4Glcb-Sp9
6GalNAca-Sp0
6GalNAca-Sp8
6Galb-Sp8
6Glcb-Sp8
8Neu5Aca-Sp8
9NAcNeu5Aca-Sp8
GlcAa-Sp8
GlcAb-Sp8
GlcNAcb1-4MDPLys
Man5-Asn
Neu5Aca-Sp11
Neu5Gca-Sp8
a-D-Gal-Sp8
a-D-Glc-Sp8
a-D-Man-Sp8
a-GalNAc-Sp8
a-L-Fuc-Sp8
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292
293
294
295
296
297
298
299
300
301
302

a-L-Fuc-Sp9
a-L-Rha-Sp8
a-NeuAc-Sp8
b-D-Gal-Sp8
b-D-Glc-Sp8
b-D-Man-Sp8
b-GalNAc-Sp8
b-GlcN(Gc)-Sp8
b-GlcNAc-Sp0
b-GlcNAc-Sp8
b-NeuAc-Sp8
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Table A-III. CFG array v2.0 tri-saccharide Features Summary
Number of Feature
0
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46

tri-saccharide
((3OSO3)(6OSO3)Galb1-4)-4(6OSO3)GlcNAcb-Sp0
((3OSO3)(6OSO3)Galb1-4)-4GlcNAcb-Sp0
((3OSO3)Galb1-3)(Fuca1-4)-3,4GlcNAcb
((3OSO3)Galb1-3)-3,4GlcNAcb-Sp8
((3OSO3)Galb1-3)-3GalNAca-Sp8
((3OSO3)Galb1-3)-3GlcNAcb-Sp8
((3OSO3)Galb1-4)-3,4GlcNAcb-Sp8
((3OSO3)Galb1-4)-4(6OSO3)GlcNAcb-Sp8
((3OSO3)Galb1-4)-4(6OSO3)Glcb-Sp0
((3OSO3)Galb1-4)-4(6OSO3)Glcb-Sp8
((3OSO3)Galb1-4)-4GlcNAcb-Sp0
((3OSO3)Galb1-4)-4GlcNAcb-Sp8
((3OSO3)Galb1-4)-4Glcb-Sp8
((4OSO3)(6OSO3)Galb1-4)-4GlcNAcb-Sp0
((4OSO3)Galb1-4)-4GlcNAcb-Sp8
((6OSO3)Galb1-4)-4(6OSO3)Glcb-Sp8
((6OSO3)Galb1-4)-4GlcNAcb-Sp8
((6OSO3)Galb1-4)-4Glcb-Sp0
((6OSO3)Galb1-4)-4Glcb-Sp8
(2,3Galb1-3)-3GlcNAcb-Sp0
(2,3Galb1-4)-3,4GlcNAcb-Sp0
(2,3Galb1-4)-4GlcNAcb-Sp0
(2,3Galb1-4)-4GlcNAcb-Sp8
(2,3Galb1-4)-4Glcb-Sp0
(2,4Galb1-4)-4GalNAcb-Sp8
(2,4Galb1-4)-4GlcNAcb-Sp8
(2Galb1-3)(Fuca1-4)-3,4GlcNAcb
(2Galb1-3)-(3GalNAcb1-3)-3Gala
(2Galb1-3)-(3GalNAcb1-3)-3Gala1
(2Galb1-3)-(3GalNAcb1-3)-3Galb1
(2Galb1-3)-(3GalNAcb1-4)-3,4Galb1
(2Galb1-3)-3,4GlcNAcb-Sp8
(2Galb1-3)-3GalNAca-Sp8
(2Galb1-3)-3GalNAcb-Sp0
(2Galb1-3)-3GalNAcb-Sp8
(2Galb1-3)-3GlcNAca-Sp8
(2Galb1-4)-(3,4GalNAcb1-3)-3Galb1
(2Galb1-4)-(4GlcNAcb1-3)-3Galb1
(2Galb1-4)-3,4GlcNAcb-Sp0
(2Galb1-4)-3,4GlcNAcb-Sp8
(2Galb1-4)-4GlcNAcb-Sp0
(2Galb1-4)-4GlcNAcb-Sp8
(2Galb1-4)-4Glcb-Sp0
(2Mana1-2)-(2Mana1-3)-3,6Manb1
(2Mana1-2)-(2Mana1-3)-3Mana
(2Mana1-2)-(2Mana1-6)-3,6Mana
(2Mana1-3)(2Mana1-6)-3,6Mana
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47
48
49
50
51
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54
55
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57
58
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84
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(2Mana1-3)(2Mana1-6)-3,6Mana1
(2Mana1-3)(2Mana1-6)-3,6Manb1
(2Mana1-3)(3,6Mana1-6)-3,6Manb1
(2Mana1-3)(Mana1-6)-3,6Mana1
(2Mana1-3)-(3,6Mana1-6)-3,6Manb1
(2Mana1-3)-(3,6Manb1-4)-4GlcNAcb1
(2Mana1-3)-3,6Mana-Sp9
(2Mana1-3)-3Mana-Sp9
(2Mana1-6)-(3,6Mana1-6)-3,6Manb1
(2Mana1-6)-(3,6Manb1-4)-4GlcNAcb1
(2Mana1-6)-3,6Mana-Sp9
(3(6-O-Su)Galb1-4)-3,4GlcNAcb-Sp8
(3(6OSO3)Galb1-4)-4GlcNAcb-Sp8
(3,4GalNAcb1-3)-(3Galb1-4)-3,4GlcNAcb
(3,4GalNAcb1-3)-(3Galb1-4)-3,4GlcNAcb1
(3,4Galb1-4)-4GlcNAcb-Sp0
(3,4Galb1-4)-4GlcNAcb-Sp8
(3,4Galb1-4)-4Glcb-Sp0
(3,4Galb1-4)-4Glcb-Sp9
(3,4GlcNAcb1-3)-(3Galb1-4)-3,4GalNAcb
(3,4GlcNAcb1-3)-(3Galb1-4)-3,4GlcNAcb
(3,4GlcNAcb1-3)-(3Galb1-4)-3,4GlcNAcb1
(3,4GlcNAcb1-3)-(3Galb1-4)-4GlcNAcb
(3,4GlcNAcb1-3)-3Galb-Sp8
(3,4GlcNAcb1-4)-(4Galb1-4)-3,4GlcNAcb
(3,4GlcNAcb1-4)-(4Galb1-4)-3,4GlcNAcb1
(3,6Galb1-4)-4GlcNAcb-Sp8
(3,6GlcNAcb1-4)-(4Galb1-4)-4Glcb
(3,6Mana1-6)-(3,6Manb1-4)-4GlcNAcb1
(3,6Manb1-4)-(4GlcNAcb1-4)-4GlcNAcb
(3GalNAcb1-3)-(3Gala1-4)-4Galb1
(3GalNAcb1-3)-(3Galb1-4)-4GlcNAcb
(3GalNAcb1-3)-(3Galb1-4)-4Glcb
(3GalNAcb1-3)-3Gala-Sp9
(3GalNAcb1-4)-(3,4Galb1-4)-4Glcb
(3GalNAcb1-4)-(4Galb1-4)-4Glcb
(3GalNAcb1-4)-4GlcNAcb-Sp0
(3Gala1-4)-(4Galb1-4)-4GlcNAcb
(3Gala1-4)-(4Galb1-4)-4Glca
(3Gala1-4)-(4Galb1-4)-4Glcb
(3Galb1-3)(3Galb1-4)-3,4GlcNAcb
(3Galb1-3)(Fuca1-4)-3,4GlcNAcb
(3Galb1-3)(Fuca1-4)-3,4GlcNAcb1
(3Galb1-3)(Neu5Aca2-6)-3,6GalNAcb
(3Galb1-3)-(3,4GlcNAcb1-3)-3Galb1
(3Galb1-3)-(3GalNAcb1-3)-3Gala1
(3Galb1-3)-(3GalNAcb1-4)-3,4Galb1
(3Galb1-3)-(3GlcNAcb1-3)-3Galb1
(3Galb1-3)-3(6OSO3)GalNAca-Sp8
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107
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118
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134
135
136
137
138
139
140
141
142
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144

(3Galb1-3)-3(6OSO3)GlcNAcb-Sp8
(3Galb1-3)-3,4GlcNAcb-Sp0
(3Galb1-3)-3,4GlcNAcb-Sp8
(3Galb1-3)-3,6GalNAcb-Sp8
(3Galb1-3)-3GalNAca-Sp8
(3Galb1-3)-3GlcNAcb-Sp0
(3Galb1-3)-3GlcNAcb-Sp8
(3Galb1-4)-(3,4GlcNAcb1-3)-3Galb
(3Galb1-4)-(3,4GlcNAcb1-3)-3Galb1
(3Galb1-4)-(4GlcNAcb1-3)-3Galb1
(3Galb1-4)-3,4(6OSO3)GlcNAcb-Sp8
(3Galb1-4)-3,4GalNAcb-Sp0
(3Galb1-4)-3,4GalNAcb-Sp8
(3Galb1-4)-3,4GlcNAcb-Sp0
(3Galb1-4)-3,4GlcNAcb-Sp8
(3Galb1-4)-4(6OSO3)GlcNAcb-Sp8
(3Galb1-4)-4GlcNAcb-Sp0
(3Galb1-4)-4GlcNAcb-Sp8
(3Galb1-4)-4Glcb-Sp0
(3Galb1-4)-4Glcb-Sp10
(3Galb1-4)-4Glcb-Sp8
(3GlcNAcb1-3)-(3Galb1-4)-4GlcNAcb
(4GalNAca1-3)-(2,3Galb1-4)-4GlcNAcb
(4GalNAcb1-3)-(2,3Galb1-4)-4GlcNAcb
(4Galb1-4)-(3,4GlcNAcb1-4)-4Galb1
(4Galb1-4)-3,4GlcNAcb-Sp0
(4Galb1-4)-4GalNAcb-Sp0
(4Galb1-4)-4GalNAcb-Sp8
(4Galb1-4)-4Galb-Sp0
(4Galb1-4)-4GlcNAcb-Sp0
(4Galb1-4)-4GlcNAcb-Sp8
(4Galb1-4)-4Glca-Sp9
(4Galb1-4)-4Glcb-Sp0
(4Galb1-4)-4Glcb-Sp10
(4Galb1-4)-4Glcb-Sp8
(4GlcNAcb1-2)-(2Mana1-3)-3,6Manb1
(4GlcNAcb1-2)-(2Mana1-6)-3,6Manb1
(4GlcNAcb1-3)(4GlcNAcb1-6)-3,6GalNAca
(4GlcNAcb1-3)-(3Galb1-4)-3,4GlcNAcb
(4GlcNAcb1-3)-(3Galb1-4)-3,4GlcNAcb1
(4GlcNAcb1-3)-(3Galb1-4)-4GlcNAcb
(4GlcNAcb1-3)-(3Galb1-4)-4GlcNAcb1
(4GlcNAcb1-3)-(3Galb1-4)-4Glcb
(4GlcNAcb1-3)-3,6GalNAca-Sp8
(4GlcNAcb1-3)-3GalNAca-Sp8
(4GlcNAcb1-4)-4GlcNAcb-Asn
(4GlcNAcb1-4)-4GlcNAcb-Gly
(4GlcNAcb1-4)-4GlcNAcb-Sp8
(4GlcNAcb1-6)-3,6GalNAca-Sp8
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177
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182
183
184
185
186
187
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190
191
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193

(4GlcNAcb1-6)-3,6GlcNAca-Sp8
(4GlcNAcb1-6)-6GalNAca-Sp8
(6GalNAcb1-4)-4GlcNAcb-Sp0
(6Galb1-4)-(4GlcNAcb1-2)-2Mana1
(6Galb1-4)-(4GlcNAcb1-3)-3Galb1
(6Galb1-4)-4(6OSO3)GlcNAcb-Sp8
(6Galb1-4)-4GlcNAcb-Sp0
(6Galb1-4)-4GlcNAcb-Sp8
(6Galb1-4)-4Glcb-Sp0
(6Galb1-4)-4Glcb-Sp8
(6Glca1-6)-6Glcb-Sp8
(8Neu5Aca2-3)(GalNAcb1-4)-3,4Galb1
(8Neu5Aca2-3)-(3,4Galb1-4)-4Glcb
(8Neu5Aca2-3)-(3Galb1-4)-4Glcb
(8Neu5Aca2-8)-(8Neu5Aca2-3)-3,4Galb1
(8Neu5Aca2-8)-(8Neu5Aca2-3)-3Galb1
(8Neu5Aca2-8)-8Neu5Aca-Sp8
(9NAcNeu5Aca2-6)-(6Galb1-4)-4GlcNAcb
(Fuca1-2)(4GalNAca1-3)-2,3Galb1
(Fuca1-2)(4GalNAcb1-3)-2,3Galb1
(Fuca1-2)(GalNAca1-3)-2,3Galb
(Fuca1-2)(GalNAca1-3)-2,3Galb1
(Fuca1-2)(GalNAca1-4)-2,4Galb1
(Fuca1-2)(GalNAcb1-3)-2,3Galb
(Fuca1-2)(Gala1-3)-2,3Galb
(Fuca1-2)(Gala1-3)-2,3Galb1
(Fuca1-2)(Gala1-4)-2,4Galb1
(Fuca1-2)-(2,3Galb1-3)-3GlcNAcb
(Fuca1-2)-(2,3Galb1-4)-3,4GlcNAcb
(Fuca1-2)-(2,3Galb1-4)-4GlcNAcb
(Fuca1-2)-(2,3Galb1-4)-4Glcb
(Fuca1-2)-(2,4Galb1-4)-4GalNAcb
(Fuca1-2)-(2,4Galb1-4)-4GlcNAcb
(Fuca1-2)-(2Galb1-3)-3,4GlcNAcb
(Fuca1-2)-(2Galb1-3)-3GalNAca
(Fuca1-2)-(2Galb1-3)-3GalNAcb
(Fuca1-2)-(2Galb1-3)-3GalNAcb1
(Fuca1-2)-(2Galb1-4)-3,4GalNAcb1
(Fuca1-2)-(2Galb1-4)-3,4GlcNAcb
(Fuca1-2)-(2Galb1-4)-4GlcNAcb
(Fuca1-2)-(2Galb1-4)-4GlcNAcb1
(Fuca1-2)-(2Galb1-4)-4Glcb
(Fuca1-2)-2,3Galb-Sp8
(Fuca1-2)-2Galb-Sp8
(Fuca1-2)-2GlcNAcb-Sp8
(Fuca1-3)((3OSO3)Galb1-4)-3,4GlcNAcb
(Fuca1-3)(2,3Galb1-4)-3,4GlcNAcb
(Fuca1-3)(2Galb1-4)-3,4GalNAcb1
(Fuca1-3)(2Galb1-4)-3,4GlcNAcb
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194
195
196
197
198
199
200
201
202
203
204
205
206
207
208
209
210
211
212
213
214
215
216
217
218
219
220
221
222
223
224
225
226
227
228
229
230
231
232
233
234
235
236
237
238
239
240
241
242

(Fuca1-3)(3(6-O-Su)Galb1-4)-3,4GlcNAcb
(Fuca1-3)(3Galb1-4)-3,4(6OSO3)GlcNAcb
(Fuca1-3)(3Galb1-4)-3,4GalNAcb
(Fuca1-3)(3Galb1-4)-3,4GlcNAcb
(Fuca1-3)(3Galb1-4)-3,4GlcNAcb1
(Fuca1-3)(4Galb1-4)-3,4GlcNAcb
(Fuca1-3)(4Galb1-4)-3,4GlcNAcb1
(Fuca1-3)(GalNAcb1-4)-3,4GlcNAcb
(Fuca1-3)(Galb1-4)-3,4GlcNAcb
(Fuca1-3)(Galb1-4)-3,4GlcNAcb1
(Fuca1-3)-(3,4GalNAcb1-3)-3Galb1
(Fuca1-3)-(3,4GlcNAcb1-3)-3Galb
(Fuca1-3)-(3,4GlcNAcb1-3)-3Galb1
(Fuca1-3)-(3,4GlcNAcb1-4)-4Galb1
(Fuca1-3)-3,4(6OSO3)GlcNAcb-Sp8
(Fuca1-3)-3,4GalNAcb-Sp0
(Fuca1-3)-3,4GalNAcb-Sp8
(Fuca1-3)-3,4GlcNAcb-Sp0
(Fuca1-3)-3,4GlcNAcb-Sp8
(Fuca1-3)-3GlcNAcb-Sp8
(Fuca1-4)-(3,4GlcNAcb1-3)-3Galb1
(Fuca1-4)-3,4GlcNAc-Sp0
(Fuca1-4)-3,4GlcNAc-Sp8
(Fuca1-4)-3,4GlcNAcb-Sp0
(Fuca1-4)-3,4GlcNAcb-Sp8
(Fuca1-4)-4GlcNAcb-Sp8
(Fucb1-3)-3GlcNAcb-Sp8
(GalNAca1-3)-(2,3Galb1-3)-3GlcNAcb
(GalNAca1-3)-(2,3Galb1-4)-3,4GlcNAcb
(GalNAca1-3)-(2,3Galb1-4)-4GlcNAcb
(GalNAca1-3)-(2,3Galb1-4)-4Glcb
(GalNAca1-3)-2,3Galb-Sp8
(GalNAca1-3)-3GalNAca-Sp8
(GalNAca1-3)-3GalNAcb-Sp8
(GalNAca1-3)-3Galb-Sp8
(GalNAca1-4)-(2,4Galb1-4)-4GlcNAcb
(GalNAcb1-3)-(3Gala1-4)-4Galb1
(GalNAcb1-3)-2,3Galb-Sp8
(GalNAcb1-4)-(3,4Galb1-4)-4GlcNAcb
(GalNAcb1-4)-(3,4Galb1-4)-4Glcb
(GalNAcb1-4)-3,4GlcNAcb-Sp0
(GalNAcb1-4)-4GlcNAcb-Sp0
(GalNAcb1-4)-4GlcNAcb-Sp8
(Gala1-2)-2Galb-Sp8
(Gala1-3)(Gala1-4)-3,4Galb1
(Gala1-3)-(2,3Galb1-3)-3GlcNAcb
(Gala1-3)-(2,3Galb1-4)-3,4GlcNAcb
(Gala1-3)-(2,3Galb1-4)-4GlcNAcb
(Gala1-3)-(2,3Galb1-4)-4Glcb
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243
244
245
246
247
248
249
250
251
252
253
254
255
256
257
258
259
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262
263
264
265
266
267
268
269
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277
278
279
280
281
282
283
284
285
286
287
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290
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(Gala1-3)-(3,4Galb1-4)-4GlcNAcb
(Gala1-3)-(3Galb1-3)-3GlcNAcb
(Gala1-3)-(3Galb1-4)-3,4GalNAcb
(Gala1-3)-(3Galb1-4)-4GlcNAcb
(Gala1-3)-(3Galb1-4)-4Glcb
(Gala1-3)-2,3Galb-Sp8
(Gala1-3)-3Galb-Sp8
(Gala1-3)-3GlcNAca-Sp8
(Gala1-3)-3GlcNAcb-Sp8
(Gala1-4)-(2,4Galb1-4)-4GalNAcb
(Gala1-4)-(3,4Galb1-4)-4GlcNAcb
(Gala1-4)-(4Galb1-4)-4GalNAcb
(Gala1-4)-(4Galb1-4)-4Galb
(Gala1-4)-4GlcNAcb-Sp8
(Gala1-6)-6Glcb-Sp8
(Galb1-2)-2Galb-Sp8
(Galb1-3)(4GlcNAcb1-6)-3,6GalNAca
(Galb1-3)(4GlcNAcb1-6)-3,6GlcNAca
(Galb1-3)(Fuca1-4)-3,4GlcNAc
(Galb1-3)(Fuca1-4)-3,4GlcNAcb
(Galb1-3)(Fuca1-4)-3,4GlcNAcb1
(Galb1-3)(GlcNAcb1-6)-3,6GalNAca
(Galb1-3)(GlcNAcb1-6)-3,6GlcNAca
(Galb1-3)(Neu5Aca2-6)-3,6GalNAca
(Galb1-3)(Neu5Aca2-6)-3,6GlcNAca
(Galb1-3)(Neu5Aca2-6)-3,6GlcNAcb1
(Galb1-3)(Neu5Acb2-6)-3,6GalNAca
(Galb1-3)(Neu5Acb2-6)-3,6GlcNAca
(Galb1-3)-(3,4GlcNAcb1-3)-3Galb1
(Galb1-3)-(3,6GlcNAcb1-4)-4Galb1
(Galb1-3)-(3GalNAcb1-3)-3Gala1
(Galb1-3)-(3GalNAcb1-3)-3Galb1
(Galb1-3)-(3GalNAcb1-4)-3,4Galb1
(Galb1-3)-(3GalNAcb1-4)-4Galb1
(Galb1-3)-3,4GlcNAc-Sp0
(Galb1-3)-3,4GlcNAc-Sp8
(Galb1-3)-3,4GlcNAcb-Sp8
(Galb1-3)-3,6GalNAca-Sp8
(Galb1-3)-3,6GlcNAca-Sp8
(Galb1-3)-3GalNAca-Sp8
(Galb1-3)-3GalNAcb-Sp8
(Galb1-3)-3Galb-Sp8
(Galb1-3)-3GlcNAcb-Sp0
(Galb1-3)-3GlcNAcb-Sp8
(Galb1-4)-(3,4GlcNAcb1-4)-4Galb1
(Galb1-4)-(4GalNAca1-3)-2,3Galb1
(Galb1-4)-(4GalNAcb1-3)-2,3Galb1
(Galb1-4)-(4GlcNAcb1-2)-2Mana1
(Galb1-4)-(4GlcNAcb1-3)-3,6GalNAca
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330
331
332
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(Galb1-4)-(4GlcNAcb1-3)-3GalNAca
(Galb1-4)-(4GlcNAcb1-3)-3Galb1
(Galb1-4)-(4GlcNAcb1-6)-3,6GalNAca
(Galb1-4)-(4GlcNAcb1-6)-3,6GlcNAca
(Galb1-4)-(4GlcNAcb1-6)-6GalNAca
(Galb1-4)-3,4GlcNAcb-Sp0
(Galb1-4)-3,4GlcNAcb-Sp8
(Galb1-4)-4(6OSO3)Glcb-Sp0
(Galb1-4)-4(6OSO3)Glcb-Sp8
(Galb1-4)-4GlcNAcb-Sp0
(Galb1-4)-4GlcNAcb-Sp8
(Galb1-4)-4Glcb-Sp0
(Galb1-4)-4Glcb-Sp8
(GlcAb1-3)-3Galb-Sp8
(GlcAb1-6)-6Galb-Sp8
(GlcNAca1-3)-(3Galb1-4)-4GlcNAcb
(GlcNAca1-6)-(6Galb1-4)-4GlcNAcb
(GlcNAcb1-2)-(2Galb1-3)-3GlcNAca
(GlcNAcb1-2)-(2Mana1-3)-3,6Manb1
(GlcNAcb1-2)-(2Mana1-6)-3,6Manb1
(GlcNAcb1-3)(GlcNAcb1-4)-3,4,6GlcNAc
(GlcNAcb1-3)(GlcNAcb1-6)-3,4,6GlcNAc
(GlcNAcb1-3)(GlcNAcb1-6)-3,6Galb1
(GlcNAcb1-3)(GlcNAcb1-6)-3,6GlcNAca
(GlcNAcb1-3)-(3,6Galb1-4)-4GlcNAcb
(GlcNAcb1-3)-(3Galb1-3)-3GalNAca
(GlcNAcb1-3)-(3Galb1-4)-4GlcNAcb
(GlcNAcb1-3)-(3Galb1-4)-4GlcNAcb1
(GlcNAcb1-3)-(3Galb1-4)-4Glcb
(GlcNAcb1-3)-3,4,6GlcNAc-Sp8
(GlcNAcb1-3)-3,6GlcNAca-Sp8
(GlcNAcb1-3)-3GalNAca-Sp8
(GlcNAcb1-3)-3Galb-Sp8
(GlcNAcb1-4)(GlcNAcb1-6)-3,4,6GlcNAc
(GlcNAcb1-4)(GlcNAcb1-6)-4,6GalNAca
(GlcNAcb1-4)-(4Galb1-4)-4GlcNAcb
(GlcNAcb1-4)-(4GlcNAcb1-4)-4GlcNAcb
(GlcNAcb1-4)-3,4,6GlcNAc-Sp8
(GlcNAcb1-4)-4,6GalNAca-Sp8
(GlcNAcb1-4)-4GlcNAcb1-Sp8
(GlcNAcb1-6)-(3,6Galb1-4)-4GlcNAcb
(GlcNAcb1-6)-(6Galb1-4)-4GlcNAcb
(GlcNAcb1-6)-3,4,6GlcNAc-Sp8
(GlcNAcb1-6)-3,6GalNAca-Sp8
(GlcNAcb1-6)-3,6GlcNAca-Sp8
(GlcNAcb1-6)-4,6GalNAca-Sp8
(GlcNAcb1-6)-6GalNAca-Sp8
(Glca1-4)-4Glca-Sp8
(Glca1-4)-4Glcb-Sp8
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343
344
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(Glca1-6)-(6Glca1-6)-6Glcb
(Glcb1-4)-4Glcb-Sp8
(Glcb1-6)-6Glcb-Sp8
(KDNa2-3)-(3Galb1-3)-3GlcNAcb
(KDNa2-3)-(3Galb1-4)-4GlcNAcb
(Mana1-2)-(2Mana1-2)-2Mana1
(Mana1-2)-(2Mana1-3)-3,6Mana
(Mana1-2)-(2Mana1-3)-3,6Mana1
(Mana1-2)-(2Mana1-3)-3,6Manb1
(Mana1-2)-(2Mana1-3)-3Mana
(Mana1-2)-(2Mana1-6)-3,6Mana
(Mana1-2)-(2Mana1-6)-3,6Mana1
(Mana1-3)(2Mana1-6)-3,6Mana
(Mana1-3)(2Mana1-6)-3,6Mana1
(Mana1-3)(3,6Mana1-6)-3,6Manb1
(Mana1-3)(Mana1-6)-3,6Mana
(Mana1-3)(Mana1-6)-3,6Mana1
(Mana1-3)(Mana1-6)-3,6Manb1
(Mana1-3)-(3,6Mana1-6)-3,6Manb1
(Mana1-3)-(3,6Manb1-4)-4GlcNAcb1
(Mana1-3)-3,6Mana-Sp9
(Mana1-6)-(3,6Mana1-6)-3,6Manb1
(Mana1-6)-(3,6Manb1-4)-4GlcNAcb1
(Mana1-6)-3,6Mana-Sp9
(Manb1-4)-4GlcNAcb-Sp0
(Neu5Aca2-3)(3GalNAcb1-4)-3,4Galb1
(Neu5Aca2-3)(GalNAcb1-4)-3,4Galb1
(Neu5Aca2-3)(Neu5Aca2-6)-3,6GalNAca
(Neu5Aca2-3)-(3(6-O-Su)Galb1-4)-3,4GlcNAcb
(Neu5Aca2-3)-(3(6OSO3)Galb1-4)-4GlcNAcb
(Neu5Aca2-3)-(3,4Galb1-4)-4GlcNAcb
(Neu5Aca2-3)-(3,4Galb1-4)-4Glcb
(Neu5Aca2-3)-(3GalNAcb1-4)-4GlcNAcb
(Neu5Aca2-3)-(3Galb1-3)-3(6OSO3)GalNAca
(Neu5Aca2-3)-(3Galb1-3)-3(6OSO3)GlcNAcb
(Neu5Aca2-3)-(3Galb1-3)-3,4GlcNAcb
(Neu5Aca2-3)-(3Galb1-3)-3,4GlcNAcb1
(Neu5Aca2-3)-(3Galb1-3)-3,6GalNAcb
(Neu5Aca2-3)-(3Galb1-3)-3GalNAca
(Neu5Aca2-3)-(3Galb1-3)-3GalNAcb1
(Neu5Aca2-3)-(3Galb1-3)-3GlcNAcb
(Neu5Aca2-3)-(3Galb1-3)-3GlcNAcb1
(Neu5Aca2-3)-(3Galb1-4)-3,4(6OSO3)GlcNAcb
(Neu5Aca2-3)-(3Galb1-4)-3,4GlcNAcb
(Neu5Aca2-3)-(3Galb1-4)-3,4GlcNAcb1
(Neu5Aca2-3)-(3Galb1-4)-4(6OSO3)GlcNAcb
(Neu5Aca2-3)-(3Galb1-4)-4GlcNAcb
(Neu5Aca2-3)-(3Galb1-4)-4GlcNAcb1
(Neu5Aca2-3)-(3Galb1-4)-4Glcb
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390
391
392
393
394
395
396
397
398
399
400
401
402
403
404
405
406
407
408
409
410
411
412
413
414
415
416
417

(Neu5Aca2-3)-3,6GalNAca-Sp8
(Neu5Aca2-3)-3GalNAca-Sp8
(Neu5Aca2-3)-3Galb-Sp8
(Neu5Aca2-6)-(3,6GlcNAcb1-4)-4Galb1
(Neu5Aca2-6)-(6GalNAcb1-4)-4GlcNAcb
(Neu5Aca2-6)-(6Galb1-4)-4(6OSO3)GlcNAcb
(Neu5Aca2-6)-(6Galb1-4)-4GlcNAcb
(Neu5Aca2-6)-(6Galb1-4)-4GlcNAcb1
(Neu5Aca2-6)-(6Galb1-4)-4Glcb
(Neu5Aca2-6)-3,6GalNAca-Sp8
(Neu5Aca2-6)-3,6GalNAcb-Sp8
(Neu5Aca2-6)-3,6GlcNAca-Sp8
(Neu5Aca2-6)-6GalNAca-Sp8
(Neu5Aca2-6)-6Galb-Sp8
(Neu5Aca2-8)-(8Neu5Aca2-3)-3,4Galb1
(Neu5Aca2-8)-(8Neu5Aca2-3)-3Galb1
(Neu5Aca2-8)-8Neu5Aca-Sp8
(Neu5Acb2-6)-(6Galb1-4)-4GlcNAcb
(Neu5Acb2-6)-3,6GalNAca-Sp8
(Neu5Acb2-6)-3,6GlcNAca-Sp8
(Neu5Acb2-6)-6GalNAca-Sp8
(Neu5Gca2-3)-(3Galb1-3)-3,4GlcNAcb
(Neu5Gca2-3)-(3Galb1-3)-3GlcNAcb
(Neu5Gca2-3)-(3Galb1-4)-3,4GlcNAcb
(Neu5Gca2-3)-(3Galb1-4)-4GlcNAcb
(Neu5Gca2-3)-(3Galb1-4)-4Glcb
(Neu5Gca2-6)-(6Galb1-4)-4GlcNAcb
(Neu5Gca2-6)-6GalNAca-Sp0
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Table A-IV. CFG array v2.0 tetra-saccharide Features Summary
Number of Features
0
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46

tetra-saccharide
((2Galb1-3)-3GalNAcb1-4)(Neu5Aca2-3)-3,4Galb1
((2Mana1-2)-2Mana1-3)(3,6Mana1-6)-3,6Manb1
((2Mana1-2)-2Mana1-6)(Mana1-3)-3,6Mana
((2Mana1-3)-3,6Mana1-6)(2Mana1-3)-3,6Manb1
((2Mana1-6)-3,6Mana1-6)(2Mana1-3)-3,6Manb1
((3,4GalNAcb1-3)-3Galb1-4)(Fuca1-3)-3,4GlcNAcb
((3,4GalNAcb1-3)-3Galb1-4)(Fuca1-3)-3,4GlcNAcb1
((3,4GlcNAcb1-3)-3Galb1-4)(Fuca1-3)-3,4GalNAcb
((3,4GlcNAcb1-3)-3Galb1-4)(Fuca1-3)-3,4GlcNAcb
((3,4GlcNAcb1-3)-3Galb1-4)(Fuca1-3)-3,4GlcNAcb1
((3,4GlcNAcb1-4)-4Galb1-4)(Fuca1-3)-3,4GlcNAcb
((3,4GlcNAcb1-4)-4Galb1-4)(Fuca1-3)-3,4GlcNAcb1
((3Galb1-3)-3GalNAcb1-4)(Neu5Aca2-3)-3,4Galb1
((3OSO3)Galb1-3)(Fuca1-4)-3,4GlcNAcb-Sp8
((4GlcNAcb1-2)-2Mana1-3)(2Mana1-6)-3,6Manb1
((4GlcNAcb1-2)-2Mana1-6)(2Mana1-3)-3,6Manb1
((4GlcNAcb1-3)-3Galb1-4)(Fuca1-3)-3,4GlcNAcb
((4GlcNAcb1-3)-3Galb1-4)(Fuca1-3)-3,4GlcNAcb1
((8Neu5Aca2-8)-8Neu5Aca2-3)(GalNAcb1-4)-3,4Galb1
((Fuca1-2)-2,3Galb1-4)(Fuca1-3)-3,4GlcNAcb
((Fuca1-2)-2Galb1-3)(Fuca1-4)-3,4GlcNAcb
((Fuca1-2)-2Galb1-4)(Fuca1-3)-3,4GalNAcb1
((Fuca1-2)-2Galb1-4)(Fuca1-3)-3,4GlcNAcb
((GalNAca1-3)-2,3Galb1-4)(Fuca1-3)-3,4GlcNAcb
((Gala1-3)-2,3Galb1-4)(Fuca1-3)-3,4GlcNAcb
((Gala1-3)-3Galb1-4)(Fuca1-3)-3,4GalNAcb
((Galb1-3)-3GalNAcb1-4)(Neu5Aca2-3)-3,4Galb1
((Galb1-4)-4GalNAca1-3)(Fuca1-2)-2,3Galb1
((Galb1-4)-4GalNAcb1-3)(Fuca1-2)-2,3Galb1
((Galb1-4)-4GlcNAcb1-3)(4GlcNAcb1-6)-3,6GalNAca
((Galb1-4)-4GlcNAcb1-6)(4GlcNAcb1-3)-3,6GalNAca
((Galb1-4)-4GlcNAcb1-6)(Galb1-3)-3,6GalNAca
((Galb1-4)-4GlcNAcb1-6)(Galb1-3)-3,6GlcNAca
((GlcNAcb1-2)-2Mana1-3)(2Mana1-6)-3,6Manb1
((GlcNAcb1-2)-2Mana1-6)(2Mana1-3)-3,6Manb1
((Mana1-2)-2Mana1-3)(2Mana1-6)-3,6Mana
((Mana1-2)-2Mana1-3)(2Mana1-6)-3,6Mana1
((Mana1-2)-2Mana1-3)(3,6Mana1-6)-3,6Manb1
((Mana1-2)-2Mana1-3)(Mana1-6)-3,6Mana1
((Mana1-2)-2Mana1-6)(2Mana1-3)-3,6Mana
((Mana1-2)-2Mana1-6)(2Mana1-3)-3,6Mana1
((Mana1-2)-2Mana1-6)(Mana1-3)-3,6Mana1
((Mana1-3)-3,6Mana1-6)(2Mana1-3)-3,6Manb1
((Mana1-3)-3,6Mana1-6)(Mana1-3)-3,6Manb1
((Mana1-6)-3,6Mana1-6)(2Mana1-3)-3,6Manb1
((Mana1-6)-3,6Mana1-6)(Mana1-3)-3,6Manb1
((Neu5Aca2-3)-3(6-O-Su)Galb1-4)(Fuca1-3)-3,4GlcNAcb
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47
48
49
50
51
52
53
54
55
56
57
58
59
60
61
62
63
64
65
66
67
68
69
70
71
72
73
74
75
76
77
78
79
80
81
82
83
84
85
86
87
88
89
90
91
92
93
94
95

((Neu5Aca2-3)-3Galb1-3)(3Galb1-4)-3,4GlcNAcb
((Neu5Aca2-3)-3Galb1-3)(Fuca1-4)-3,4GlcNAcb
((Neu5Aca2-3)-3Galb1-3)(Fuca1-4)-3,4GlcNAcb1
((Neu5Aca2-3)-3Galb1-3)(Neu5Aca2-6)-3,6GalNAcb
((Neu5Aca2-3)-3Galb1-4)(3Galb1-3)-3,4GlcNAcb
((Neu5Aca2-3)-3Galb1-4)(Fuca1-3)-3,4(6OSO3)GlcNAcb
((Neu5Aca2-3)-3Galb1-4)(Fuca1-3)-3,4GlcNAcb
((Neu5Aca2-3)-3Galb1-4)(Fuca1-3)-3,4GlcNAcb1
((Neu5Aca2-8)-8Neu5Aca2-3)(GalNAcb1-4)-3,4Galb1
((Neu5Gca2-3)-3Galb1-3)(Fuca1-4)-3,4GlcNAcb
((Neu5Gca2-3)-3Galb1-4)(Fuca1-3)-3,4GlcNAcb
(2Galb1-3)(Fuca1-4)-3,4GlcNAcb-Sp8
(2Galb1-3)-(3GalNAcb1-3)-(3Gala1-4)4Galb1
(2Galb1-3)-(3GalNAcb1-3)-(3Galb1-4)4Glcb
(2Galb1-3)-(3GalNAcb1-3)-3Gala-Sp9
(2Galb1-4)(Fuca1-3)-(3,4GalNAcb1-3)-3Galb1
(2Galb1-4)-(3,4GalNAcb1-3)-(3Galb1-4)3,4GlcNAcb
(2Galb1-4)-(3,4GalNAcb1-3)-(3Galb1-4)3,4GlcNAcb1
(2Galb1-4)-(4GlcNAcb1-3)-(3Galb1-4)4GlcNAcb
(2Galb1-4)-(4GlcNAcb1-3)-(3Galb1-4)4GlcNAcb1
(2Mana1-2)-(2Mana1-3)-3Mana-Sp9
(2Mana1-2)-(2Mana1-6)-3,6Mana-Sp9
(2Mana1-3)(2Mana1-6)-3,6Mana-Sp9
(2Mana1-6)(2Mana1-3)-(3,6Mana1-6)-3,6Manb1
(2Mana1-6)(2Mana1-3)-(3,6Manb1-4)-4GlcNAcb1
(2Mana1-6)(Mana1-3)-(3,6Mana1-6)-3,6Manb1
(2Mana1-6)-(3,6Mana1-6)-(3,6Manb1-4)4GlcNAcb1
(2Mana1-6)-(3,6Manb1-4)-(4GlcNAcb1-4)4GlcNAcb
(3,4GalNAcb1-3)-(3Galb1-4)-3,4GlcNAcb-Sp0
(3,4GlcNAcb1-3)-(3Galb1-4)-3,4GalNAcb-Sp0
(3,4GlcNAcb1-3)-(3Galb1-4)-3,4GlcNAcb-Sp0
(3,4GlcNAcb1-3)-(3Galb1-4)-4GlcNAcb-Sp0
(3,4GlcNAcb1-3)-(3Galb1-4)-4GlcNAcb-Sp8
(3,4GlcNAcb1-4)-(4Galb1-4)-(3,4GlcNAcb1-4)4Galb1
(3,4GlcNAcb1-4)-(4Galb1-4)-3,4GlcNAcb-Sp0
(3,6GlcNAcb1-4)-(4Galb1-4)-4Glcb-Sp10
(3,6Mana1-6)(2Mana1-3)-(3,6Manb1-4)-4GlcNAcb1
(3,6Mana1-6)(Mana1-3)-(3,6Manb1-4)-4GlcNAcb1
(3,6Mana1-6)-(3,6Manb1-4)-(4GlcNAcb1-4)4GlcNAcb
(3,6Manb1-4)-(4GlcNAcb1-4)-4GlcNAcb-Asn
(3,6Manb1-4)-(4GlcNAcb1-4)-4GlcNAcb-Gly
(3,6Manb1-4)-(4GlcNAcb1-4)-4GlcNAcb-Sp8
(3GalNAcb1-3)-(3Galb1-4)-4GlcNAcb-Sp0
(3GalNAcb1-3)-(3Galb1-4)-4Glcb-Sp10
(3GalNAcb1-3)-(3Galb1-4)-4Glcb-Sp8
(3GalNAcb1-4)(Neu5Aca2-3)-(3,4Galb1-4)-4Glcb
(3GalNAcb1-4)-(3,4Galb1-4)-4Glcb-Sp0
(3GalNAcb1-4)-(3,4Galb1-4)-4Glcb-Sp9
(3GalNAcb1-4)-(4Galb1-4)-4Glcb-Sp8
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96
97
98
99
100
101
102
103
104
105
106
107
108
109
110
111
112
113
114
115
116
117
118
119
120
121
122
123
124
125
126
127
128
129
130
131
132
133
134
135
136
137
138
139
140
141
142
143
144

(3Gala1-4)-(4Galb1-4)-4GlcNAcb-Sp0
(3Gala1-4)-(4Galb1-4)-4Glca-Sp9
(3Gala1-4)-(4Galb1-4)-4Glcb-Sp0
(3Galb1-3)(3Galb1-4)-3,4GlcNAcb-Sp8
(3Galb1-3)(Fuca1-4)-3,4GlcNAcb-Sp0
(3Galb1-3)(Fuca1-4)-3,4GlcNAcb-Sp8
(3Galb1-3)(Neu5Aca2-6)-3,6GalNAcb-Sp8
(3Galb1-3)-(3,4GlcNAcb1-3)-(3Galb1-4)3,4GlcNAcb
(3Galb1-3)-(3GalNAcb1-3)-(3Gala1-4)4Galb1
(3Galb1-3)-(3GlcNAcb1-3)-(3Galb1-4)4GlcNAcb
(3Galb1-4)(Fuca1-3)-(3,4GlcNAcb1-3)-3Galb
(3Galb1-4)(Fuca1-3)-(3,4GlcNAcb1-3)-3Galb1
(3Galb1-4)-(3,4GlcNAcb1-3)-(3Galb1-4)3,4GalNAcb
(3Galb1-4)-(3,4GlcNAcb1-3)-(3Galb1-4)3,4GlcNAcb
(3Galb1-4)-(3,4GlcNAcb1-3)-(3Galb1-4)3,4GlcNAcb1
(3Galb1-4)-(3,4GlcNAcb1-3)-(3Galb1-4)4GlcNAcb
(3Galb1-4)-(3,4GlcNAcb1-3)-3Galb-Sp8
(3Galb1-4)-(4GlcNAcb1-3)-(3Galb1-4)3,4GlcNAcb
(3Galb1-4)-(4GlcNAcb1-3)-(3Galb1-4)4GlcNAcb
(3Galb1-4)-(4GlcNAcb1-3)-(3Galb1-4)4GlcNAcb1
(3GlcNAcb1-3)-(3Galb1-4)-4GlcNAcb-Sp0
(4GalNAca1-3)(Fuca1-2)-(2,3Galb1-4)-4GlcNAcb
(4GalNAca1-3)-(2,3Galb1-4)-4GlcNAcb-Sp8
(4GalNAcb1-3)(Fuca1-2)-(2,3Galb1-4)-4GlcNAcb
(4GalNAcb1-3)-(2,3Galb1-4)-4GlcNAcb-Sp8
(4Galb1-4)(Fuca1-3)-(3,4GlcNAcb1-4)-4Galb1
(4Galb1-4)-(3,4GlcNAcb1-4)-(4Galb1-4)3,4GlcNAcb
(4GlcNAcb1-3)(4GlcNAcb1-6)-3,6GalNAca-Sp8
(4GlcNAcb1-3)-(3Galb1-4)-3,4GlcNAcb-Sp0
(4GlcNAcb1-3)-(3Galb1-4)-4GlcNAcb-Sp0
(4GlcNAcb1-3)-(3Galb1-4)-4Glcb-Sp0
(4GlcNAcb1-3)-(3Galb1-4)-4Glcb-Sp8
(6Galb1-4)-(4GlcNAcb1-2)-(2Mana1-3)3,6Manb1
(6Galb1-4)-(4GlcNAcb1-2)-(2Mana1-6)3,6Manb1
(6Galb1-4)-(4GlcNAcb1-3)-(3Galb1-4)3,4GlcNAcb1
(6Galb1-4)-(4GlcNAcb1-3)-(3Galb1-4)4GlcNAcb
(8Neu5Aca2-3)-(3,4Galb1-4)-4Glcb-Sp0
(8Neu5Aca2-3)-(3Galb1-4)-4Glcb-Sp0
(8Neu5Aca2-8)-(8Neu5Aca2-3)-(3,4Galb1-4)4Glcb
(8Neu5Aca2-8)-(8Neu5Aca2-3)-(3Galb1-4)4Glcb
(9NAcNeu5Aca2-6)-(6Galb1-4)-4GlcNAcb-Sp8
(Fuca1-2)(GalNAca1-3)-2,3Galb-Sp8
(Fuca1-2)(GalNAcb1-3)-2,3Galb-Sp8
(Fuca1-2)(Gala1-3)-2,3Galb-Sp8
(Fuca1-2)-(2,3Galb1-3)-3GlcNAcb-Sp0
(Fuca1-2)-(2,3Galb1-4)-3,4GlcNAcb-Sp0
(Fuca1-2)-(2,3Galb1-4)-4GlcNAcb-Sp0
(Fuca1-2)-(2,3Galb1-4)-4GlcNAcb-Sp8
(Fuca1-2)-(2,3Galb1-4)-4Glcb-Sp0
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145
146
147
148
149
150
151
152
153
154
155
156
157
158
159
160
161
162
163
164
165
166
167
168
169
170
171
172
173
174
175
176
177
178
179
180
181
182
183
184
185
186
187
188
189
190
191
192
193

(Fuca1-2)-(2,4Galb1-4)-4GalNAcb-Sp8
(Fuca1-2)-(2,4Galb1-4)-4GlcNAcb-Sp8
(Fuca1-2)-(2Galb1-3)-3,4GlcNAcb-Sp8
(Fuca1-2)-(2Galb1-3)-3GalNAca-Sp8
(Fuca1-2)-(2Galb1-3)-3GalNAcb-Sp0
(Fuca1-2)-(2Galb1-3)-3GalNAcb-Sp8
(Fuca1-2)-(2Galb1-4)-3,4GlcNAcb-Sp0
(Fuca1-2)-(2Galb1-4)-3,4GlcNAcb-Sp8
(Fuca1-2)-(2Galb1-4)-4GlcNAcb-Sp0
(Fuca1-2)-(2Galb1-4)-4GlcNAcb-Sp8
(Fuca1-2)-(2Galb1-4)-4Glcb-Sp0
(Fuca1-3)((3OSO3)Galb1-4)-3,4GlcNAcb-Sp8
(Fuca1-3)(2,3Galb1-4)-3,4GlcNAcb-Sp0
(Fuca1-3)(2Galb1-4)-3,4GlcNAcb-Sp0
(Fuca1-3)(2Galb1-4)-3,4GlcNAcb-Sp8
(Fuca1-3)(3(6-O-Su)Galb1-4)-3,4GlcNAcb-Sp8
(Fuca1-3)(3Galb1-4)-3,4(6OSO3)GlcNAcb-Sp8
(Fuca1-3)(3Galb1-4)-3,4GalNAcb-Sp0
(Fuca1-3)(3Galb1-4)-3,4GalNAcb-Sp8
(Fuca1-3)(3Galb1-4)-3,4GlcNAcb-Sp0
(Fuca1-3)(3Galb1-4)-3,4GlcNAcb-Sp8
(Fuca1-3)(4Galb1-4)-3,4GlcNAcb-Sp0
(Fuca1-3)(GalNAcb1-4)-3,4GlcNAcb-Sp0
(Fuca1-3)(Galb1-4)-3,4GlcNAcb-Sp0
(Fuca1-3)(Galb1-4)-3,4GlcNAcb-Sp8
(Fuca1-3)-(3,4GalNAcb1-3)-(3Galb1-4)3,4GlcNAcb
(Fuca1-3)-(3,4GalNAcb1-3)-(3Galb1-4)3,4GlcNAcb1
(Fuca1-3)-(3,4GlcNAcb1-3)-(3Galb1-4)3,4GalNAcb
(Fuca1-3)-(3,4GlcNAcb1-3)-(3Galb1-4)3,4GlcNAcb
(Fuca1-3)-(3,4GlcNAcb1-3)-(3Galb1-4)3,4GlcNAcb1
(Fuca1-3)-(3,4GlcNAcb1-3)-(3Galb1-4)4GlcNAcb
(Fuca1-3)-(3,4GlcNAcb1-3)-3Galb-Sp8
(Fuca1-4)(3Galb1-3)-(3,4GlcNAcb1-3)-3Galb1
(Fuca1-4)(Galb1-3)-(3,4GlcNAcb1-3)-3Galb1
(Fuca1-4)-(3,4GlcNAcb1-3)-(3Galb1-4)3,4GlcNAcb
(Fuca1-4)-(3,4GlcNAcb1-3)-(3Galb1-4)4GlcNAcb
(GalNAca1-3)(Fuca1-2)-(2,3Galb1-3)-3GlcNAcb
(GalNAca1-3)(Fuca1-2)-(2,3Galb1-4)-3,4GlcNAcb
(GalNAca1-3)(Fuca1-2)-(2,3Galb1-4)-4GlcNAcb
(GalNAca1-3)(Fuca1-2)-(2,3Galb1-4)-4Glcb
(GalNAca1-3)-(2,3Galb1-3)-3GlcNAcb-Sp0
(GalNAca1-3)-(2,3Galb1-4)-3,4GlcNAcb-Sp0
(GalNAca1-3)-(2,3Galb1-4)-4GlcNAcb-Sp0
(GalNAca1-3)-(2,3Galb1-4)-4GlcNAcb-Sp8
(GalNAca1-3)-(2,3Galb1-4)-4Glcb-Sp0
(GalNAca1-4)(Fuca1-2)-(2,4Galb1-4)-4GlcNAcb
(GalNAca1-4)-(2,4Galb1-4)-4GlcNAcb-Sp8
(GalNAcb1-4)(8Neu5Aca2-3)-(3,4Galb1-4)-4Glcb
(GalNAcb1-4)(Neu5Aca2-3)-(3,4Galb1-4)-4GlcNAcb
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194
195
196
197
198
199
200
201
202
203
204
205
206
207
208
209
210
211
212
213
214
215
216
217
218
219
220
221
222
223
224
225
226
227
228
229
230
231
232
233
234
235
236
237
238
239
240
241
242

(GalNAcb1-4)(Neu5Aca2-3)-(3,4Galb1-4)-4Glcb
(GalNAcb1-4)-(3,4Galb1-4)-4GlcNAcb-Sp0
(GalNAcb1-4)-(3,4Galb1-4)-4GlcNAcb-Sp8
(GalNAcb1-4)-(3,4Galb1-4)-4Glcb-Sp0
(Gala1-3)(Fuca1-2)-(2,3Galb1-3)-3GlcNAcb
(Gala1-3)(Fuca1-2)-(2,3Galb1-4)-3,4GlcNAcb
(Gala1-3)(Fuca1-2)-(2,3Galb1-4)-4GlcNAcb
(Gala1-3)(Fuca1-2)-(2,3Galb1-4)-4Glcb
(Gala1-3)-(2,3Galb1-3)-3GlcNAcb-Sp0
(Gala1-3)-(2,3Galb1-4)-3,4GlcNAcb-Sp0
(Gala1-3)-(2,3Galb1-4)-4GlcNAcb-Sp0
(Gala1-3)-(2,3Galb1-4)-4Glcb-Sp0
(Gala1-3)-(3,4Galb1-4)-4GlcNAcb-Sp8
(Gala1-3)-(3Galb1-3)-3GlcNAcb-Sp0
(Gala1-3)-(3Galb1-4)-3,4GalNAcb-Sp8
(Gala1-3)-(3Galb1-4)-4GlcNAcb-Sp8
(Gala1-3)-(3Galb1-4)-4Glcb-Sp0
(Gala1-4)(Fuca1-2)-(2,4Galb1-4)-4GalNAcb
(Gala1-4)(Gala1-3)-(3,4Galb1-4)-4GlcNAcb
(Gala1-4)-(2,4Galb1-4)-4GalNAcb-Sp8
(Gala1-4)-(3,4Galb1-4)-4GlcNAcb-Sp8
(Gala1-4)-(4Galb1-4)-4GalNAcb-Sp0
(Gala1-4)-(4Galb1-4)-4GalNAcb-Sp8
(Gala1-4)-(4Galb1-4)-4Galb-Sp0
(Galb1-3)(4GlcNAcb1-6)-3,6GalNAca-Sp8
(Galb1-3)(4GlcNAcb1-6)-3,6GlcNAca-Sp8
(Galb1-3)(Fuca1-4)-3,4GlcNAc-Sp0
(Galb1-3)(Fuca1-4)-3,4GlcNAc-Sp8
(Galb1-3)(Fuca1-4)-3,4GlcNAcb-Sp8
(Galb1-3)(GlcNAcb1-6)-3,6GalNAca-Sp8
(Galb1-3)(GlcNAcb1-6)-3,6GlcNAca-Sp8
(Galb1-3)(Neu5Aca2-6)-3,6GalNAca-Sp8
(Galb1-3)(Neu5Aca2-6)-3,6GlcNAca-Sp8
(Galb1-3)(Neu5Acb2-6)-3,6GalNAca-Sp8
(Galb1-3)(Neu5Acb2-6)-3,6GlcNAca-Sp8
(Galb1-3)-(3,4GlcNAcb1-3)-(3Galb1-4)3,4GlcNAcb
(Galb1-3)-(3,4GlcNAcb1-3)-(3Galb1-4)4GlcNAcb
(Galb1-3)-(3GalNAcb1-3)-(3Gala1-4)4Galb1
(Galb1-3)-(3GalNAcb1-3)-(3Galb1-4)4GlcNAcb
(Galb1-3)-(3GalNAcb1-3)-(3Galb1-4)4Glcb
(Galb1-4)(Fuca1-3)-(3,4GlcNAcb1-4)-4Galb1
(Galb1-4)-(3,4GlcNAcb1-4)-(4Galb1-4)3,4GlcNAcb
(Galb1-4)-(3,4GlcNAcb1-4)-(4Galb1-4)3,4GlcNAcb1
(Galb1-4)-(4GalNAca1-3)-(2,3Galb1-4)4GlcNAcb
(Galb1-4)-(4GalNAcb1-3)-(2,3Galb1-4)4GlcNAcb
(Galb1-4)-(4GlcNAcb1-2)-(2Mana1-3)3,6Manb1
(Galb1-4)-(4GlcNAcb1-2)-(2Mana1-6)3,6Manb1
(Galb1-4)-(4GlcNAcb1-3)-(3Galb1-4)3,4GlcNAcb1
(Galb1-4)-(4GlcNAcb1-3)-(3Galb1-4)4GlcNAcb
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243
244
245
246
247
248
249
250
251
252
253
254
255
256
257
258
259
260
261
262
263
264
265
266
267
268
269
270
271
272
273
274
275
276
277
278
279
280
281
282
283
284
285
286
287
288
289
290
291

(Galb1-4)-(4GlcNAcb1-3)-(3Galb1-4)4GlcNAcb1
(Galb1-4)-(4GlcNAcb1-3)-(3Galb1-4)4Glcb
(Galb1-4)-(4GlcNAcb1-3)-3,6GalNAca-Sp8
(Galb1-4)-(4GlcNAcb1-3)-3GalNAca-Sp8
(Galb1-4)-(4GlcNAcb1-6)-3,6GalNAca-Sp8
(Galb1-4)-(4GlcNAcb1-6)-3,6GlcNAca-Sp8
(Galb1-4)-(4GlcNAcb1-6)-6GalNAca-Sp8
(GlcNAca1-3)-(3Galb1-4)-4GlcNAcb-Sp8
(GlcNAca1-6)-(6Galb1-4)-4GlcNAcb-Sp8
(GlcNAcb1-2)-(2Galb1-3)-3GlcNAca-Sp8
(GlcNAcb1-3)(GlcNAcb1-4)(GlcNAcb1-6)-3,4,6GlcNAc
(GlcNAcb1-3)(GlcNAcb1-4)-3,4,6GlcNAc-Sp8
(GlcNAcb1-3)(GlcNAcb1-6)-3,4,6GlcNAc-Sp8
(GlcNAcb1-3)(GlcNAcb1-6)-3,6GlcNAca-Sp8
(GlcNAcb1-3)-(3,6Galb1-4)-4GlcNAcb-Sp8
(GlcNAcb1-3)-(3Galb1-3)-3GalNAca-Sp8
(GlcNAcb1-3)-(3Galb1-4)-4GlcNAcb-Sp0
(GlcNAcb1-3)-(3Galb1-4)-4GlcNAcb-Sp8
(GlcNAcb1-3)-(3Galb1-4)-4Glcb-Sp0
(GlcNAcb1-4)(GlcNAcb1-6)-3,4,6GlcNAc-Sp8
(GlcNAcb1-4)(GlcNAcb1-6)-4,6GalNAca-Sp8
(GlcNAcb1-4)-(4Galb1-4)-4GlcNAcb-Sp8
(GlcNAcb1-4)-(4GlcNAcb1-4)-4GlcNAcb-Sp8
(GlcNAcb1-6)(GlcNAcb1-3)-(3,6Galb1-4)-4GlcNAcb
(GlcNAcb1-6)-(3,6Galb1-4)-4GlcNAcb-Sp8
(GlcNAcb1-6)-(6Galb1-4)-4GlcNAcb-Sp8
(Glca1-6)-(6Glca1-6)-6Glcb-Sp8
(KDNa2-3)-(3Galb1-3)-3GlcNAcb-Sp0
(KDNa2-3)-(3Galb1-4)-4GlcNAcb-Sp0
(Mana1-2)-(2Mana1-2)-(2Mana1-3)3,6Manb1
(Mana1-2)-(2Mana1-2)-(2Mana1-3)3Mana
(Mana1-2)-(2Mana1-2)-(2Mana1-6)3,6Mana
(Mana1-2)-(2Mana1-3)-3,6Mana-Sp9
(Mana1-2)-(2Mana1-3)-3Mana-Sp9
(Mana1-2)-(2Mana1-6)-3,6Mana-Sp9
(Mana1-3)(2Mana1-6)-3,6Mana-Sp9
(Mana1-3)(Mana1-6)-3,6Mana-Sp9
(Mana1-6)(2Mana1-3)-(3,6Mana1-6)-3,6Manb1
(Mana1-6)(Mana1-3)-(3,6Mana1-6)-3,6Manb1
(Mana1-6)(Mana1-3)-(3,6Manb1-4)-4GlcNAcb1
(Mana1-6)-(3,6Mana1-6)-(3,6Manb1-4)4GlcNAcb1
(Mana1-6)-(3,6Manb1-4)-(4GlcNAcb1-4)4GlcNAcb
(Neu5Aca2-3)(Neu5Aca2-6)-3,6GalNAca-Sp8
(Neu5Aca2-3)-(3(6-O-Su)Galb1-4)-3,4GlcNAcb-Sp8
(Neu5Aca2-3)-(3(6OSO3)Galb1-4)-4GlcNAcb-Sp8
(Neu5Aca2-3)-(3,4Galb1-4)-4GlcNAcb-Sp0
(Neu5Aca2-3)-(3,4Galb1-4)-4GlcNAcb-Sp8
(Neu5Aca2-3)-(3,4Galb1-4)-4Glcb-Sp0
(Neu5Aca2-3)-(3,4Galb1-4)-4Glcb-Sp9
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292
293
294
295
296
297
298
299
300
301
302
303
304
305
306
307
308
309
310
311
312
313
314
315
316
317
318
319
320
321
322
323
324
325
326
327
328
329
330
331

(Neu5Aca2-3)-(3GalNAcb1-4)-4GlcNAcb-Sp0
(Neu5Aca2-3)-(3Galb1-3)-(3,4GlcNAcb1-3)3Galb1
(Neu5Aca2-3)-(3Galb1-3)-(3GalNAcb1-3)3Gala1
(Neu5Aca2-3)-(3Galb1-3)-(3GalNAcb1-4)3,4Galb1
(Neu5Aca2-3)-(3Galb1-3)-(3GlcNAcb1-3)3Galb1
(Neu5Aca2-3)-(3Galb1-3)-3(6OSO3)GalNAca-Sp8
(Neu5Aca2-3)-(3Galb1-3)-3(6OSO3)GlcNAcb-Sp8
(Neu5Aca2-3)-(3Galb1-3)-3,4GlcNAcb-Sp8
(Neu5Aca2-3)-(3Galb1-3)-3,6GalNAcb-Sp8
(Neu5Aca2-3)-(3Galb1-3)-3GalNAca-Sp8
(Neu5Aca2-3)-(3Galb1-3)-3GlcNAcb-Sp0
(Neu5Aca2-3)-(3Galb1-3)-3GlcNAcb-Sp8
(Neu5Aca2-3)-(3Galb1-4)-3,4(6OSO3)GlcNAcb-Sp8
(Neu5Aca2-3)-(3Galb1-4)-3,4GlcNAcb-Sp0
(Neu5Aca2-3)-(3Galb1-4)-3,4GlcNAcb-Sp8
(Neu5Aca2-3)-(3Galb1-4)-4(6OSO3)GlcNAcb-Sp8
(Neu5Aca2-3)-(3Galb1-4)-4GlcNAcb-Sp0
(Neu5Aca2-3)-(3Galb1-4)-4GlcNAcb-Sp8
(Neu5Aca2-3)-(3Galb1-4)-4Glcb-Sp0
(Neu5Aca2-3)-(3Galb1-4)-4Glcb-Sp8
(Neu5Aca2-6)(Galb1-3)-(3,6GlcNAcb1-4)-4Galb1
(Neu5Aca2-6)-(3,6GlcNAcb1-4)-(4Galb1-4)4Glcb
(Neu5Aca2-6)-(6GalNAcb1-4)-4GlcNAcb-Sp0
(Neu5Aca2-6)-(6Galb1-4)-(4GlcNAcb1-2)2Mana1
(Neu5Aca2-6)-(6Galb1-4)-(4GlcNAcb1-3)3Galb1
(Neu5Aca2-6)-(6Galb1-4)-4(6OSO3)GlcNAcb-Sp8
(Neu5Aca2-6)-(6Galb1-4)-4GlcNAcb-Sp0
(Neu5Aca2-6)-(6Galb1-4)-4GlcNAcb-Sp8
(Neu5Aca2-6)-(6Galb1-4)-4Glcb-Sp0
(Neu5Aca2-6)-(6Galb1-4)-4Glcb-Sp8
(Neu5Aca2-8)-(8Neu5Aca2-3)-(3,4Galb1-4)4Glcb
(Neu5Aca2-8)-(8Neu5Aca2-3)-(3Galb1-4)4Glcb
(Neu5Aca2-8)-(8Neu5Aca2-8)-8Neu5Aca-Sp8
(Neu5Acb2-6)-(6Galb1-4)-4GlcNAcb-Sp8
(Neu5Gca2-3)-(3Galb1-3)-3,4GlcNAcb-Sp0
(Neu5Gca2-3)-(3Galb1-3)-3GlcNAcb-Sp0
(Neu5Gca2-3)-(3Galb1-4)-3,4GlcNAcb-Sp0
(Neu5Gca2-3)-(3Galb1-4)-4GlcNAcb-Sp0
(Neu5Gca2-3)-(3Galb1-4)-4Glcb-Sp0
(Neu5Gca2-6)-(6Galb1-4)-4GlcNAcb-Sp0
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